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ABSTRACT 
An abstract of the thesis of Steffen Koehler for the Master of Science in Physics presented 
July 6, 1995. 
Title: 0-Phthalaldehyde Modification of Sarcoplasmic Reticulum 
Calcium Release 
Muscle contraction is a phenomena which fascinated already the ancient Greeks. People 
have long sought to understand the mechanism of muscle contraction. Today we know 
that in order for muscle to contract, an action potential propagates from the nerve cell to 
the muscle cell. Upon arriving at the muscle cell, via a mechanism called Excitation-
Contraction (E-C) coupling, Ca2+ is released from an intracellular membrane system, the 
sarcoplasmic reticulum (SR), into the intracellular fluid. The increase of intracellular Ca2+ 
initiates the interaction between the contractile units which results in force development 
and tension. The least well understood step in the contractile process is mechanism of E-C 
coupling. During the last 15-20 years various theories have been proposed to describe this 
process. Our laboratory came up with a theory several years ago, that critical sultbydryl 
groups on a protein, the ryanodine receptor(RyR)/Ca2+ release channel, are oxidized and 
subsequently reduced during the process of contraction and relaxation. In this thesis a 
reagent, o-Phthalaldehyde (OPA), was used to better understand the gating mechanism of 
the RyR/Ca2+ release channel. This reagent has the ability to form an isoindole derivative 
with the amino acids cysteine and lysine, if they are separated by not more than 3 A .In this 
study, it was shown that OP A interacts directly with the Ca2+ release channel by forming a 
covalent derivative with a critical thiol and a nearby lysine. High affinity [3H]Ryanodine 
binding to the RyR\Ca2+ release channel is activated by < 130µM OP A, but is inhibited by 
OPA at concentrations ranging from 200-300 µM OPA. This biphasic behavior indicates 
that at least two sets of cysteine-lysine pairs regulate Ca2+ channel activity. Moreover, the 
binding of OP A results in increasing the affinity of the receptor for the binding of 
ryanodine, in a Ca2+ independent manner, which may indicate that there are two different 
sets of RyR\Ca2+ release channels present in the SR. 
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CHAPTER I 
1 THE CALCIUM RELEASE CHANNEL 
1.1 INTRODUCTION 
Calcium ions are the most important second messenger in biological systems. Ca2+ is 
involved in the control of enzyme activity, neurotransmitter release, secretion, calcium 
activated potassium channel opening, and in the control of muscle contraction. 
Muscle contraction and force development depends on the intracellular Ca2+ 
concentration. After the muscle cell becomes stimulated by the attached neuron, the 
intracellular Ca2+ concentration increases and the contractile proteins, the myofibrils, are 
caused to contract. To relax the muscle, the intracellular Ca2+ must be decreased. A 
intracellular membrane system, the sarcoplasmic reticulum, is responsible for regulating 
the intracellular Ca2+ concentration. The mechanism by which it decreases the Ca2+ 
concentration is well known, while the mechanism of releasing Ca2+ out of the 
sarcoplasmic reticulum remains unknown. 
The focus of this thesis is the study of the mechanism of Ca2+ release from white 
rabbit skeletal muscle sarcoplasmic reticulum. 
1.2 MORPHOLOGY OF THE MUSCLE 
1.2.1 Muscle in general 
There are three types of muscles: skeletal, smooth and cardiac muscle. Cardiac 
muscle is only found in the heart. Skeletal muscle is connected to the skeletal system 
through tendons. Smooth muscle is composed of far smaller fibers, usually 2 µm to 5 µm 
in diameter and only 50 µm to 200 µm in length, in contrast to the skeletal muscle fibers 
that are as much as 20 times as wide (in diameter) and thousand of times as long. Of the 
three muscle types, skeletal muscle responds most quickly to electrical stimulation (2-5 
ms). Cardiac muscle is slightly slower than skeletal muscle (20-50 ms), and is more 
regulated by hormonal effectors. Smooth muscle is slower than both cardiac and skeletal 
muscle, and contains a poorly defined sarcoplasmic reticulum. The mechanism underlying 
smooth muscle contraction is similar to that found in skeletal and cardiac muscle. 
Essentially the same chemical substances cause contraction in smooth muscle as in skeletal 
muscle, but the physical arrangement of smooth muscle fibers is entirely different. 
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1.2.2 Physiologic anatomy of skeletal muscle 
Skeletal muscle contains numerous fibers ranging in size from 10 µm to 80 µm in 
diameter. These muscle fibers are surrounded by a plasma membrane which is called the 
sarcolemma (SL). The muscle cell has up to 100 nuclei and mitochondria. In most muscles 
the fibers extend the entire length of the muscle. The end of the muscle fiber is connected 
to tendons which are inserted into the bones. 
Each muscle fiber consists of hundreds to thousands of myofibrils. These myofibrils 
are responsible for muscle contraction. They are made up largely of actin and myosin 
filaments. Electron micrographs display a well defined striated pattern of the myofibrils. 
The actin filaments are attached on both sides of the Z-disc, which passes from 
myofibril to myofibril to attach all the myofibrils in one muscle fiber. The regions where 
only the actin filaments are located, are called the I-bands, because they are isotropic to 
polarized light. These bands appear light under the electron microscope. The region where 
the myosin and actin filaments overlap is called the A-band, because it is anisotropic to 
polarized light. On the surface of the myosin filaments there are a lot of so called cross-
bridges that can interact with the actin filaments and cause muscle contraction. They are 
located all over the myosin filament except for the very middle. The region in the middle 
of two Z-discs which consists only of myosin filaments is called the H-band. The region of 
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Figure 1 Organization of skeletal muscle, from the gross to the molecular level. F, G, H, and I are 
cross-sections at the levels indicated. (From Bloom and Fawcett: A Textbook of Histology. 
Philadelphia, W. B. Saunders Company, 1975.) 
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Figure 2 The transverse tubule-sarcoplasmic reticulum system ( From Bloom and Fawcett: A 
Textbook of Histology. Philadelphia, W. B. Saunders Company, 1975. Modified after Peachey: J. 
Cell Biol. 25:209, 1965.) 
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the myofibril which is between two Z-discs is called a sarcomere. It has a length of 2 µm if 
the muscle is in its resting state. 
During contraction and relaxation only the Hand I-band change their length, while 
the I-band always shortens or lengthens symmetrically with respect to the Z-disc. In the 
resting state the actin filaments totally overlap the myosin filaments and they slightly 
overlap each other. If the muscle is stretched then the actin filaments don't overlap 
anymore and at the center of the A-band there is only the myosin filament and the H-band 
is visible. 
To understand the molecular mechanism of contraction, one has to examine in more 
detail the interaction between myosin and actin. The myosin filament is composed of about 
200 myosin molecules, each having a molecular weight of about 480,000. The myosin 
molecule consists of 2 heavy (200,000) and four light (20,000) polypeptide chains. The 
two heavy chains coil around each other to form a double helix. At one end of this double 
helix chain, each chain is folded into a globular protein mass called the myosin head. The 
other end of this double helix chain is called the tail. The four light chains are parts of the 
myosin heads, two to each head. The tails of the myosin are bundled together to form the 
body of the filament. In addition to the tail, the helix part of the chain provides an 
extension outward from the body along with the head, which is called the arm. The head 
and the arm together is called the cross-bridge, and it is believed that it is flexible at two 
positions (hinges). One position is where the arm leaves the body of the myosin filament 
and the other where the two heads attach to the arm. The hinged arms allow the heads to 
move either far away from the body or to come closer. The hinged heads are very 
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important for the actual contraction process. The myosin filament is twisted so that 
successive sets of cross-bridges are axially displaced from the previous set by 120 degrees, 
and so that the cross-bridges extend in all directions around the filament. 
The actin filament is composed of three different components: actin, tropomyosin, 
and troponin. The backbone of the actin filament is a doublestranded F-actin protein 
molecule. The two strands are wound in a helix with a complete revolution every 70 nm. 
Each of the two strands is composed of polymerized G-actin molecules with a molecular 
weight of 42,000. For each revolution there are about 13 molecules in each strand. To 
every G-actin molecule there is one molecule of ADP attached. These ADP molecules are 
the active sites on the actin filaments with which the cross-bridges interact to cause muscle 
contraction. Therefore there is one active site every 2.7 nm on the actin filament. 
In addition, the actin filament contains two tropomyosin strands which are loosely 
attached to one F-actin strand, respectively. This protein strand which consists of a 
polymer of tropomyosin molecules covers the active sites during the resting state of the 
muscle, and prevents the interaction between the actin and myosin filaments. 
Troponin, which is made up of three globular protein molecules, is also attached to 
the actin filament. One of the three globular proteins (Troponin I) has a strong affinity for 
actin, another (Troponin T) for tropomyosin, and the third (Troponin C) strongly binds 
calcium ions. The task of this complex is to attach the tropomyosin to the actin. The 
calcium binding complex is responsible for activating the muscle contraction. 
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The myofibrils are suspended inside the muscle fiber in a matrix called sarcoplasm, 
which is composed of intracellular constituents. The fluid of the sarcoplasm contains large 
quantities of potassium, magnesium, phosphate, and soluble enzymes. In addition there are 
a lot of mitochondria and an extensive endoplasmic reticulum, which in the muscle fiber is 
called the sarcoplasmic reticulum. The mitochondria is responsible for creating ATP, and 
the sarcoplasmic reticulum is extremely important for the muscle contraction because of 
its ability to store and release calcium ions. 
1.3 EXCITATION-CONTRACTION COUPLING: SYSTEMS AND PROTEINS 
INVOLVED 
1.3.1 General model 
Initiation of contraction in skeletal muscle begins with the arrival of the action 
potential in the muscle fiber. Skeletal muscle fibers are excited by large myelinated nerve 
fibers. The innervate skeletal muscle fibers at the neuromuscular junction are located near 
the middle of the muscle fiber so that the action potential can spread out from the middle 
to both ends of the fiber allowing nearly coincident contraction of all sarcomeres of the 
muscle. 
The sarcolemma invagination at the position of the Z-disc is called the transverse 
tubule (T-tubule). These T-tubules allow the action potential to travel through the entire 
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thickness of the muscle fiber, and therefore every myofibril can be rapidly affected by the 
penetrating action potential. After the action potential has traveled down the T-tubule, the 
sarcoplasmic reticulum releases calcium ions. These ions bind to troponin C which allows 
actin and myosin to interact in the presence of ATP. The actin and myosin move closer 
together and this results in a production of tension. 
Muscle contraction will continue until the calcium ion concentration in the 
sarcoplasmic fluid is reduced to resting levels (0.6-1.0 µM). Immediately after the calcium 
is released from the sarcoplasmic reticulum another protein which is called the Mg2+ -Ca2+ -
ATPase pumps these calcium ions back into the SR by hydrolyzing ATP to ADP and Pi. 
For each mole of ATP hydrolyzed, 2 mole of Ca2+ are transported into the SR. The free 
calcium concentration in the sarcoplasmic fluid decreases and inhibits the interaction 
between actin and myosin which leads to muscle relaxation. In order to maintain a longer 
contraction of the muscle, a series of action potentials has to propagate along the 
sarcolemma. 
1.3.2 Sarcoplasmic Reticulum 
The sarcoplasmic reticulum (SR) is a membrane system surrounding the myofibrils 
and is responsible for controlling the intracellular Ca2+ concentration in skeletal and cardiac 
muscle. One of the two main proteins in the SR are the Ca2+-Mg2+-ATPase and the 
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Calcium Release Channel. The A TPase, a 105 kDa protein, pumps Ca2+ ions into the SR in 
order to obtain a calcium gradient across the SR membrane. 
Ca2+ is released following an action potential which stimulates the SR Ca2+ release 
channel. This Ca2+ diffuses into the sarcoplasm because of a high Ca2+ gradient across the 
membrane. After the channel has opened, the calcium pump immediately starts to 
transport the calcium ions back into the SR. This entire cycle of Ca2+ release and uptake 
can be completed in a time range of milliseconds.56 
The SR is structurally organized in two distinct regions: longitudinal SR and 
junctional SR GSR) or terminal cistemae. The longitudinal SR stretches along the length 
of each sarcomere and connects the terminal cistemae which is located at each end of the 
sarcomere. The junctional SR is generally sac-like and thicker than the longitudinal region. 
It is found on both sides of the Z-disc adjacent to the T-tubule. The association of the 
terminal cistemae and the T-tubule forms a triad. 
By means of density-gradient centrifugation it was possible to identify two distinct 
fractions of the SR: light SR (LSR) and heavy SR (HSR). It has been shown that LSR is 
isolated from the longitudinal region while HSR contains membranes from the terminal 
cistemae59·>. LSR contains 90% of the Mg2+-Ca2+-ATPase pumps. The principal function 
of the light SR is to pump the calcium back into the SR following Ca2+ release. 
The HSR is composed of proteins from the LSR along with the Ca2+ release channel 
and calsequestrin. Calsequestrin, a protein associated with the junctional face 
membrane1s.),3L>.90·> has a high capacity and a low affinity for calcium binding29·>. Therefore 
during the resting phase of the contractile process most of the calcium in the SR diffuses 
10 
to the terminal cistemae region and binds to calsequestrin. Thus, the terminal cistemae is 
responsible for both storing and releasing of calcium ions. 
It is believed that the calcium release protein is mainly localized in the terminal 
cistemae region of the SR. Experiments with SR vesicles from light and heavy SR 
fractions showed that the calcium release rates are much higher from heavy SR vesicles 
than from light SR vesicles.61 
Electron micrographs reveal several proteins embedded in the terminal cistemae 
membrane of the SR, and a gap between the SR and the T-tubule of approximately56 120-
170 A. The junctional foot protein (JFP) is a homotetramer (i.e., it is composed of 4 equal 
subunits) and is localized in the terminal cistemae region with a molecular weight106 of 
about 535,000. From analysis of the amino acid sequence, approximately one tenth of each 
subunit (high molecular weight protein) forms a transmembrane region, while the 
remainder of the protein lies outside the membrane, and is considered the foot which spans 
the gap between the SR and the T-tubule. 
In addition to being identified as the calcium release channel and the JFP, this 
protein also binds with high affinity the plant alkaloid ryanodine. 
1.3.3 Ryanodine receptor/Ca2+ release channel 
Excitable and nonexcitable cells contain one or both of two intracellular Ca2+ release 
channels. Release of Ca2+ from intramembrane compartments can be triggered by the 
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binding of the second messenger inositol 1,4,5-trisphosphate (IP3) to the IP3 receptor/Ca
2
+ 
release channel. It also can be mediated by the ryanodine receptor (RyR)/Ca2+ release 
channel in response to a surface membrane action potential and/or a change in the 
concentration of a second messenger by a mechanism referred to in muscle as excitation-
contraction (E-C) coupling. 
In muscle at the junctional region of the SR, large protein structures are present that 
span the gap between the SR and the transverse tubule. These structures have been termed 
feet and are now commonly known as ryanodine receptor/Ca2+ release channels because of 
the presence of an intrinsic Ca2+ channel activity , and the ability to bind the plant alkaloid 
ryanodine with high affinity and specificity. The RyR ion channel has been purified from 
muscle and neural tissue as a 30 S protein complex comprised of 4 polypetides of about 
5000 amino acid residues each. 
From a variety of tissues including rabbit skeletal muscle36.48' 101 the RyR has been 
purified with retention of its [3H]ryanodine binding and intrinsic channel activities. In most 
of these studies, the membrane-bound RyR was solubilized using the zwitterionic 
detergent CHAPS and high ionic strength (1.0 M NaCl) and then, as shown by density 
gradient centrifugation, purified as a 30 S protein complex. 
SDS gel electrophoresis suggests that the purified RyRs of mammalian skeletal and 
cardiac muscle7•39•40•48 , brain47'58, crustacean skeletal muscle96 , and C. elegans46 contain a 
single major high molecular weight polypeptide with a calculated Mr of about 560,000, as 
determined by cloning and sequencing of the complementary DNA of the mammalian 
skeletal and cardiac muscle RyR isoforms.73•75•107•122 
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Electron microscopy studies have revealed that the purified 30 S RyRs of 
mammalian skeletal48'92 and cardiac7 muscle and brain48 have an overall morphology 
identical to the protein bridges (feet) that span the T-tubule-SR junctional gap in isolated 
SR fractions of vertebrate skeletal muscle. The four leaf clover-like ( quatrefoil) 
appearance of negative-stained samples, the apparent sedimentation coefficient of 30 S48, 
and crosslinking49 and scanning transmission electron microscopy studies93 have 
demonstrated a tetrameric assembly of the high molecular weight subunits of the CHAPS-
purified skeletal RyR. Studies with averaged images of negatively stained118 and frozen 
hydrated84 specimens indicate an overall dimension of 27x27x14 nm for the skeletal RyR 
(resolution of about 3 nm). 
The primary structure of three mammalian RyR isoforms has been determined by 
cDNA cloning and sequencing. The isoforms are encoded by three different genes coding 
for a skeletal muscle (RyR1)107' 122 cardiac muscle (RyR2) 73'75, and brain (RyR3).33 
Expression studies with the skeletal and cardiac muscle cDNAs in cultured cells and 
Xenophus oocytes suggest that the Mr 560,000 polypeptides are sufficient to form 
ryanodine-, caffeine- and Ca2+-sensitive Ca2+ channels.38'73 ' 107 The skeletal muscle cDNA 
encodes a protein of 5032-5037 amino acids, whereas the cardiac muscle and brain 
cDNAs were found to encode proteins of 4968-497 6 and 4872 amino acids, respectively. 
Comparison of the predicted amino acid sequences of the skeletal and cardiac muscle and 
brain receptors reveals a large number of conserved regions throughout the sequence of 
the three Ry Rs with an overall identity of 66-70% and greater than 90% in the 250 amino 
acid carboxy-terminal portion. The only other protein shown so far to display significant 
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sequence homology with the RyR is the IP3 receptor ion channel, which is similarly 
comprised of four polypeptides of 2701-27 49 amino acids each. 12 
Hydropathy plots suggest that the Mr 560,000 polypeptides consist of two major 
structural regions: the carboxy-terminal pore region, which is thought to consist of as few 
as four107 and as many as ten or possibly twelve122 putative transmembrane segments, 
presumably the Ca2+ release channel, and a large extramembrane region, which is thought 
to correspond to the cytoplasmic foot structure. 
It was shown 48 that the complete tetramer is necessary for ryanodine binding and 
channel activity. 
1.3.4 Transverse Tubule 
The T-tubule is an invagination of the sarcolemma deep into the muscle fiber, but 
the protein components of these two membrane systems are quite different. It was found 
that the average density of the Na+-K+-ATPase in T-tubules is about 6 times less than in 
the SL 114• In addition the density of Na+ channels in the T-tubule is 4 times less than it is in 
the SL. One the other hand, calcium channels are 3 to 4 times more dense in the T-tubule 
than in the SL. 
The major problems in examining the structure and function of the T-tubule are its 
small size, and the difficulty in isolating adequate amounts of T-tubule vesicles. Also when 
isolated, contamination with SR and/or SL proteins is likely. Therefore different 
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preparations of T-tubule membranes show varying amounts of different protein 
components. Reports range from 15 to 27 different proteins. 
Interaction between the SR and T-tubule occurs at specialized junctions called 
peripheral couplings, dyads and triads or, collectively E-C units. Peripheral couplings are 
formed between one SR cisternae and the SL. Dyads and triads are internal junctions 
comprised of either one or two junctional SR cisternae and a T-tubule segment. Muscle 
fibers of different species have various combinations of these three types of junctions. 
Electron microscopy reveals the location and structure of the junctional foot protein, 
which spans the gap between the SR and the T-tubule. It has four large subunits 
symmetrically located around a central less dense area. Ordered disposition and close 
proximity between adjacent feet are maintained in isolated SR vesicles.68 The center to 
center distance between feet in arrays is 26-32 nm in muscles of vertebrates and 27-28 nm 
in invertebrates. The arrangement, although tetragonal in both cases, differs slightly. 
The quatrefoil foot structure is readily visible in the isolated RyR molecule, but the 
latter has an additional feature: a smaller, stain-excluding or raised central platform that 
also shows a four subunit structure and is rotated by 45°. The platform presumably 
corresponds to the intramembrane domain of the molecule. Indeed, in freeze-fracture 
replicas of the junctional SR membrane, a small intramembrane quatrefoil is revealed at the 
location of each foot13 • Feet have unique large cytoplasmic domains that may directly 
contact components of the T-tubules. 
On the basis of immunocytochemistry and the structural similarity between feet and 
purified RyR, it is reasonable to assume that all arrays of feet found in EMs of skeletal 
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muscle are composed of RyRs. The converse is not necessarily true, i.e., the lack of 
detection of feet by EM does not exclude the presence of RyRs in cases where the 
molecules do not form an array, since single feet are difficult to detect in EMs. 
From these observations one knows that SR Ca2+ release channels in skeletal muscle 
are located in the SR membrane immediately adjacent to the T-tubules. 
1.3.5 Dihydropyridine Receptor (DHPR) 
A high percentage of the proteins found in T-tubules are slowly activating Ca2+ 
channels known as dihydropyridine (DHP) sensitive calcium channels.90 The gating 
characteristics of these channels are sensitive to several DHPs. 
These channels probably have two important roles in the process of muscle 
contraction4'32' 108• First, they supply calcium to the myoplasm, which is essential for the 
contraction process. Most of these calcium channels are found in the T-tubule, not in the 
SL.108 Analysis of DHP binding shows that T-tubules bind 50 pmole DHP/mg membrane, 
versus isolated SL which only binds 1.5 pmole DHP/mg membrane. Also, less than 0.005 
U/mg Ca2+-ATPase activity is detected in the SL, compared to 2.42 U/mg activity in SR.90 
However, less than 5% of the high affinity DHP binding sites in intact skeletal 
muscle are actually functional Ca2+ channels. These results were obtained by measuring 
DHP binding to intact skeletal muscle and comparing these results with voltage clamp 
measurements of Ca2+ channel block.95 To block the the current, 100 to 1000 fold the 
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expected concentration of DHP was necessary. Yet it has been observed that low 
concentrations of a DHP inhibit both SR Ca2+ release and charge movement which is 
recorded just before contraction. 86 
This charge movement is due to a movement of charged protein groups located in 
the T-tubule membrane. These proteins have been postulated to be the voltage sensors of 
E-C coupling.9•87•109·11l DHPRs are composed of one each of five subunits 
(a. 1 ,a. 2 ,~,y,8)
17 '23 , all of which have been sequenced and expressed.26'67 '89•108•110 The a. 1 
subunit is channel forming and contains the DHP-binding site of the molecule.67•70•74•78•108 
Dysgenic muscle has been an essential tool in understanding the role of DHPRs. A 
point mutation in the gene for a. 1 subunit of DHPR
24
'
109 results in undetectable levels of 
the protein and reduction, but not total absence, of specific DHP binding.81 '85 The decrease 
in DHP binding, lack of slow inward calcium currents and charge movement, and 
interruption of E-C coupling in dysgenic fibers, and the rescue of functions and currents in 
fibers transfected with the cDNA for the DHPR constitute compelling evidence for 
identification of DHPRs with the voltage sensors of E-C coupling. 
cDNA for cardiac DHPR, expressed in dysgenic cells, results in Ca2+ currents with 
fast cardiac-type kinetics and in E-C coupling that is dependent on extracellular110 Ca2+. In 
experiments using various skeletal-cardiac cDNA chimeras, the components responsible 
for the faster kinetics of the cardiac DHPR and for the ability to sustain skeletal muscle 
type E-C coupling (independent of extracellular Ca2+) have been identified. 
In the T-tubule a group of four proteins is found with the help of the EM. This 
group is called tetrads. The images show that the four components of the tetrads are 
17 
located almost exactly above the four subunits of the feet, which strongly indicates that 
feet and tetrads can interact with each other. There are some indirect lines of evidence that 
the tetrads are composed of four DHPRs. The strongest is that tetrads are missing in 
dysgenic myotubes, which lack normal DHPRs24'82, but small clusters of them are present 
in these myotubes after transfecting them with the cDNA for the missing DHPRs. 105 
1.3.6 Calcium channels (general) 
A number of ion channels exist to help generate an electric field across membranes. 
Using the Goldman equation, one can calculate the transmembrane potential, given the 
relative ionic permeability and ionic concentrations on the two sides of the membrane. 
Channels are usually named according the specific ion that most favorably passes through 
them. Both cation (Ca2+,Na+,K+) and anion (Cr) channels exist. Within the same cell, two 
channels can conduct the same ions but they may differ in kinetics, conductance and 
threshold mechanism. Channel activation may occur due to ligand binding or due to 
changes in the transmembrane electrical potential. Ligand activation occurs when a 
chemical reagent binds to an appropriate site on the channel, and as a consequence, 
channel gating is modified. Voltage gated channels are activated by a change in the 
transmembrane potential. Calcium channels in the brain and nerve cells or the potassium 
and sodium channels in the nerve cells, which are responsible for the action potential, are 
voltage-gated ion channels. 
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Calcium channels can be divided into 3 categories according to their kinetics. 57 L-
type, T-type, and N-type channels. L-type channels are found in the heart and in the T-
tubules of skeletal muscle cells. They have long-lasting (>700 ms), non-inactivating 
currents. They are also activated by high voltage and have a relatively high Ba2+ 
conductance of 25 pS. The T-type channels have transient currents which inactivate 
completely after 50 ms. They are activated at low voltage and they have a small Ba2+ 
conductance of 8 pS. Normally they are found in neurons. The N-type channel is an 
intermediate of the L- and T-type channel. It inactivates quickly (50 ms) but needs to be 
activated by high voltage and is intermediate in Ba2+ conductance (13 pS). 
Skeletal muscle contains at least two types of Ca2+ channels, one with fast and one 
with slow kinetics. 10 The DHP-sensitive Ca2+ channel in the T-tubule has a slowly 
inactivating Ca2+ current (L-type channel). 
Since the Ca2+ channel of the SR is not located in the outer muscle cell membrane, it 
can't be examined with the patch clamp technique. Therefore this channel is not 
categorized as a L, T, or N type channel. 
The RyR/Ca2+ release channel is a cation-selective channel that displays an unusually 
large ion conductance for monovalent ( :::::600 and :::::750pS with symmetric 500 mM Na+ 
and 250 mM K+ as the current carrier, respectively) and divalent ( :::::100-150 pS with 50 
mM Ca2+ trans) cations. 
Reconstitution of the CHAPS-purified skeletal muscle RyR channel into planar lipid 
bilayers reveals several novel features. They are not readily observed in studies with the 
native release channel because of the presence of SR K+ and Cr channels, which are also 
19 
incorporated into the bilayers during SR vesicle fusion. The purified RyR channel displays 
a high conductance for Ca2+ and monovalent cations and high selectivity for cations over 
anions. 4&,s 1, 101 
The appearance of multiple subconductance states present within the channel 
tetramer is a frequently observed phenomenon upon reconstitution of the detergent-
solubilized purified channel.51 ' 101 Three subconductances were apparent that correspond to 
114, 112, and 3/4 of the native conductance level. Appearance of multiple conductances 
has been proposed to be due either to the presence of a channel comprised of four 
subunits, each containing an individually conducting pore, or a single conducting pore 
present in several discrete conductance states within the tetrameric assembly of the Mr 
560,000 subunits. In either case cooperative interactions among the subunits must occur 
to account for the multiple conductance behavior of the release channel. 
The observation of an essentially identical conductance behavior of various RyRs 
suggests that the pore of the RyR ion channel is highly conserved. In agreement with this 
prediction, the putative pore region in the C-terminal domain shows a high extent of 
sequence similarity among the mammalian skeletal, cardiac, and brain RyR isoforms.33 
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1.4 MODELS OF EXCITATION-CONTRACTION COUPLING 
1.4.1 Introduction 
Excitation contraction coupling means the link between the excitation of the 
motomeuron and the contraction of the muscle cell. The manner in which the T-tubule 
communicates with the SR to open the calcium release channel remains a mystery. 
In cardiac muscle, E-C coupling is dependent on extracellular Ca2+. A plasmalemmal 
dihydropyridine-sensitive Ca2+ current represents a major pathway for the entry of 
extracellular Ca2+ during an action potential. 11 The resulting rise in intracellular Ca2+ 
concentration is thought to trigger the massive release of Ca2+ from the SR by opening 
RyR ion channels18'71 closely apposed to the plasmalemma in structural complexes called 
couplings. 103 
Morphological 103 and more recent immunocytochemical42 .44 and [3H]ryanodine 
binding44 studies showing the presence of an appreciable portion of RyRs without any 
plasmalemmal contact in mammalian ( corbular SR) and avian (extended junctional SR) 
heart suggest that the cardiac RyR may be activated by Ca2+ or some other effector in the 
absence of a close association with the cardiac dihydropyridine receptor (DHPR)/Ca2+ 
channel. 
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However, in skeletal muscle, E-C coupling is independent of extracellular 
calcium.8•21 •23•87 Many models have been proposed, but the mechanism is still unresolved. 
Three models for E-C coupling exist: electrical, mechanical and chemical coupling. 
There are different ways to study the E-C coupling. Among the most important are 
measurements of high affinity [3H]ryanodine binding, vesicle Ca2+ flux experiments, planar 
bilayer membrane reconstitution experiments, and SDS gel electrophoresis. 
1.4.2 Electrical coupling 
The motomeuron sets up an electrical impulse in the muscle cell which propagates 
along the membrane and the T-tubule deep into the muscle. Therefore, the idea of 
electrical coupling is reasonable. The coupling would occur by depolarizing the SR 
membrane, which would cause the opening of the Ca2+ release channel (CRC). Eisenberg27 
showed by theoretical considerations that capacitative coupling is very unlikely. However, 
since the JFP lies between the SR and T-tubule, an electrical signal may propagate along 
this protein from the T-tubule to the SR and cause a depolarization. The theory of the 
depolarization is unlikely, because there exists only a gradient for calcium across the SR 
membrane. In addition the CRC, when reconstituted in lipid bilayer, is only slightly voltage 
dependent. 
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1.4.3 Mechanical coupling 
Mechanical coupling proposes that effects of charge movement in the T-tubule 
membrane may induce calcium release from the SR by a direct molecular interaction 
between components of the two membranes. Depolarization could cause a conformational 
change of the JFP and therefore open the CRC with the foot part of the JFP serving as a 
plunger. 
Conversely, it is known that an alternate disposition of tetrads is found in some 
muscles (i.e. the distance between tetrads is twice that between adjacent feet) which 
results in tetrads being associated with alternate feet. There is little evidence that the 
disposition of tetrads in rabbit muscle varies in different areas of the same muscle and/or 
the same fiber. Verifying this finding of a variable ratio of tetrads to feet would greatly 
weaken the direct mechanical coupling hypothesis. In addition, assuming a direct 
interaction, it is unclear why the four subunits of the RyR, acting as a single functional 
unit2°·64, should need four DHPRs.50 
On the other hand, there are also findings which support the mechanical coupling 
hypothesis. In skeletal muscle, all arrays of feet are located at junctional sites, which is 
consistent with their possible role in direct transduction of the DHPR-generated signal. In 
muscles that depend on extracellular Ca2+ for E-C coupling (cardiac muscle and muscles of 
invertebrates), feet may also be found in corbular or extended junctional SR membranes, 
which do not face surface membraneff-tubules. 104 RyR identity of feet on corbular SR has 
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been confirmed by immunolabeling. If these free feet participate in E-C coupling, they 
must be activated by some indirect mechanism. Conversely, the obligatory position of 
vertebrate feet in the junctional gap would indicate that skeletal muscle E-C coupling, 
which is independent of extracellular Ca2+, requires close proximity of feet to DHPR-
bearing T-tubule membrane. 
In the search for components of the junction that may be responsible either for 
holding feet and DHPRs together, or for allowing them to interact with each other, triadin 
has been identified. 22 Triadin is a 95 kD glycoprotein and abundant component of E-C 
units (approximately 1: 1 stoichiometry with the foot protein) that forms multimeric 
assemblies; it is joined covalently by disulfide bonds. Its location in the terminal cistemae 
of the SR has been confirmed by immunocytochemistry. 19 
There are a few observations which are relevant to the question of a possible 
intermediate component between DHPRs and RyRs. First, dysgenic myofibers in vivo 
have some respectable looking triads, complete with ordered, apparently normal rows of 
feet, despite the lack of DHPRs. This can be interpreted as either the association between 
feet and T-tubule membrane is mediated by a protein other than DHPRs, or a different 
calcium channel, such as the one detected by Adams and Beam3, substitutes for DHPRs in 
the formation of these triads, although such a channel does not participate in E-C 
coupling. 
In other experiments Chinese Hamster Ovary (CHO) cells were co-transfected with 
both the cDNAs from a skeletal-cardiac chimeria of the DHPR and from the RyR. 106 
Calcium currents indicate appropriate insertion of DHPRs in the surface membrane; 
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Electron micrographs show correct feet insertion in ER membranes; and caffeine shows 
function of at least a fraction of the feet. However no tetrads are seen, and no junction is 
formed between the DHPR-bearing surface membrane and the feet-bearing ER, which 
suggests the lack of a structural component necessary for junction formation. 
At present, the mechanical coupling model is supported by a number of 
investigations in this field. 
1.4.4 Chemical Coupling 
Several chemical compounds are capable of opening and closing the CRC. Not all of 
them are physiologically present, but they have been used to study the behavior of the 
calcium channel. Ca 2+ is believed to trigger the calcium channel in the heart. This 
mechanism is called Ca2+-induced Ca2+ release. However, in skeletal muscle this 
mechanism is not applicable, because experiments with skinned fibers show that 
contraction takes place even in the absence of extracellular calcium in the T-tubule and in 
the presence of Cd2+ which blocks calcium flux through the calcium channels in the T -
tubules.54 In addition, the kinetics of the DHP-sensitive Ca2+ channels don't fit with the 
time scale of contraction. Calcium currents through skeletal muscle DHP sensitive Ca2+ 
channels are slower and longer lasting than is activation of contraction.5 
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1.4.4.1 Phosphorylation by inositol 1,4,5-triphosphat (IP3) 
In other tissues, IP3 causes calcium release from the endoplasmic reticulum. Thus, 
these calcium channels are called IP3 receptors. IP3 also causes calcium release from 
purified SR fractions from skeletal muscle and in skinned fibers it causes a force 
production. 117 Yet, IP3 doesn't cause Ca
2
+ release from SR vesicles and it doesn't modify 
ryanodine binding. Vergara et al. 115 showed that electrical stimulation of the muscle causes 
a production of IP3• A model was proposed in which depolarization of the T-tubule 
membrane stimulates phospholipase C activity that hydrolyzes phosphatidyl-
inositol(4,5)diphosphate (PIP2) to IP3• The IP3 then diffuses to the calcium channel and 
opens it. The main argument against this model is that an adequate amount of IP3 is not 
produced and can't diffuse in such a short time to the calcium channel. In addition, the 
slow response of skinned skeletal muscle fibers to IP3, generated by the photolysis of 
caged119 IP3, and the inability of microinjected heparin to block SR Ca
2
+ release in skeletal 
muscle fibers 77 have argued against IP3 as a primary regulatory ligand in E-C coupling. 
Also IP3 and its non-hydrolyzable analogue IPS3 have been shown to activate the t-tubule 
DHP-sensitive Ca2+ channel. 116 
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1.4.4.2 Sulfhydryl Oxidation 
Abramson and Salama2 proposed that the calcium channel is gated by oxidation-
reduction reactions of sulfhydryl groups (SH). The model suggests that an oxidation of 
two sulfhydryl groups to a disulfide linkage opens the channel and a reduction of this 
disulfide linkage closes the channel. Heavy metals, which bind to SH groups trigger 
calcium release. The stimulation of Ca2+ release by heavy metals correlates strongly with 
the affinity of those metal ions for SH containing agents. 1 Ag+ also releases calcium most 
effectively under physiological conditions (i.e., at pH 7.0 and 1 mM free94 Mg2+). 
The fluorogenic sulfhydryl probe 7-diethylamino-3-(4' -maleimidedylphenyl)-4-
methylcoumarin (CPM) has been used to characterize the functional role and location of 
highly reactive thiol groups on the ryanodine-sensitive calcium release channel complex of 
skeletal and cardiac junctional SR. 52 The kinetics of the formation of fluorescent CPM 
adducts was highly dependent on the presence of physiological and pharmacological 
modulators of the ryanodine receptor calcium release channel. Pretreatment of the 
ryanodine receptor with the agonist Ca2+ (micromolar) and ryanodine (nanomolar) leads to 
a slow SR thiol-CPM reaction. On the other hand, in the presence of Ca2+ channel 
antagonists (millimolar Ca2+, millimolar Mg2+, or micromolar ryanodine ), CPM rapidly 
forms adducts with a single class of highly reactive (hyperreactive) SR thiols. 
Nonreducing sodium dodecyl sulfate-polyacrylamide gel electrophoresis of CPM-
labeled SR proteins, and Western plot analyses with antiryanodine or antitriadin antibodies 
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reveal that the hyperreactive thiols labeled by CPM under conditions favoring channel 
closure are localized principally on the RyR protomer and triadin. 
These results show that the RyR and triadin contain a small number of highly 
reactive cysteine residues that selectively conjugate with CPM only when channel closure 
is favored. Two possible interpretations exist. Either the redox state of the critical 
sulfhydryl group controls the channel or the accessibility of this thiol is determined by the 
conformational state of the channel. 
There are a other experiments which speak for the first interpretation. Covalent 
modification of hyperreactive thiols with nanomolar CPM inhibits both Ca2+ -induced Ca2+ 
release and the gating activity of single channels reconstituted in bilayers. Also 1,4-
naphthoquinone, which selectively oxidizes hyperreactive thiols on the RyR and triadin, 
releases Ca2+ from SR vesicles, without inhibiting Ca2+-Mg2+-ATPase activity. In other 
works oxidizing reagents cause Ca2+ release from SR vesicles and activates single channel 
activity in the lipid bilayer.52 
In summary, these experiments support a proposed model of redox control of 
channel gating. It has been shown that the Ca2+ release rates from SR vesicles induced by 
the thiol reagent94 Ag+, and induced by the reactive disulfide compound 2,2'-
dithiodipyridine (2,2'-DTDP) are maximal121 at pH 7.0. Moreover, oxidation of thiols in 
an environment without protein, is maximal at around pH 8.0. The amino acid lysine, with 
its free E amine, can lower the pKa of nearby thiols. 14 
Thus, lysine may influence the reactivity of thiols at pH 7 .0, that are important for 
Ca2+ release channel gating. 
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1.4.5 Other Proteins interacting with the RyR 
In addition to triadin, calsequestrin may also play an important role in E-C coupling. 
Calsequestrin is a major mammalian skeletal muscle SR Ca2+ -binding protein that is 
concentrated in the terminal cisternae of SR. Observations of calsequestrin protein 
conformational changes preceding those of the RyR suggest that calsequestrin, in addition 
to increasing the Ca2+ storage capacity of SR, may have an active role in regulating SR 
Ca2+ release. 37 
1.5 PHARMACOLOGY OF SR CALCIUM RELEASE 
There are several chemical compounds which are able to modulate Ca2+ release from 
SR vesicles. These modulators either inhibit or stimulate Ca2+ release and play an 
important role in examining the calcium release channel. 
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1.5.1 Inhibitors of Ca2+ release 
Ruthenium red inhibits Ca2+ release from isolated SR vesicles62•94•113 and inhibits the 
single channel activity in the lipid bilayer.99 This inhibitor is effective at concentrations less 
than 5 µM. 
Mg2+ inhibits muscle fiber contraction28•30, Ca2+ release from isolated SR vesicles62 
and single channel activity in lipid bilayer.100 It is less effective than ruthenium red, but it is 
more physiologically relevant because the Mg2+ concentration in muscle cells is between 
0.6 and 1.0 mM. Inhibition of Ca2+ release from SR vesicles occurs above 1-2 mM Mg2+. 
In single channel measurements, calmodulin inhibited the release channel by 
reducing the channel open time without having an apparent effect on single channel 
conductance. 102 Channel inhibition with calmodulin is Ca2+-dependent, reversible, and only 
partial (two to threefold), rather than complete. Inhibition is observed under assay 
conditions that varied 45Ca2+ release rates from heavy SR vesicles by> 1000-fold.63 
1.5.2 Stimulators of Ca2+ release: 
The interaction between Ca2+ and the Ca2+ release channel is biphasic. Low 
concentrations (> 1 µM) stimulate the release of Ca2+ from SR vesicles and high 
concentrations (> 1 mM) inhibit the release. It is believed that there are two Ca2+ binding 
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sites on the release channel. The high affinity binding site is responsible for channel 
opening, and the low affinity binding site for channel closure. Mg2+ inhibition of the Ca2+ 
channel opening is probably due to competition with Ca2+ for the same binding site. In 
addition, Mg2+ , sterically blocks the channel as it binds to a site near the conducting 
pathway. This biphasic behavior has also been shown for single channels in lipid bilayers. 
Ca2+-induced Ca2+ release can be greatly potentiated by millimolar concentrations of 
ATP.66•69•72 Optimal channel activation was found in the presence of µM Ca2+ and mM 
ATP (AMP-PCP) in SR vesicles62'72 and single channel measurements. 100 Various other 
adenine nucleotides (AMP-PCP, ADP, AMP, cAMP, adenosine, adenine) potentiate Ca2+ 
release, which suggests that activation occurs because of binding to an effector site rather 
than covalent modification of the channel protein via a phosphorylation reaction, because 
AMP-PCP is a non-hydrolyzable ATP analogue. It is likely that MgATP, rather than free 
ATP, is a major physiological regulator of the RyR ion channel because most of the 
nucleotide in cells is complexed with Mg2+. The addition of Mg2+ and adenine nucleotide 
at concentrations approximating those in muscle ( 5 mM each, 0. 7 mM free Mg2+) was 
strongly stimulatory at µM Ca2+ and indicated the existence of a regulatory site that, upon 
binding of MgATP, rendered the channel more sensitive to activation in a narrower Ca2+ 
concentration range.62 In the presence of µM Ca2+ and 5 mM AMP-PCP, a change in free 
Mg2+ concentration from 0.1 to 4 mM had a profound inhibitory effect on Ca2+ efflux, 
which suggests that free Mg2+ may be an important effector of in vivo SR Ca2+ release. 
31 
Ryanodine is also known to show a biphasic behavior. At low concentrations (nM) it 
stimulates, and a higher concentrations (µM) it closes the Ca2+ release channel. This was 
seen with SR vesicles and on the single channel level. 16a 
Caffeine is known to activate muscle fiber contraction34 and stimulates Ca2+ release 
from SR vesicles. Actually caffeine doesn't stimulate Ca2+ release by itself, but sensitizes 
the channel to Ca2+ (i.e., a lower Ca2+ concentration is needed to activate the channel.80) 
1.6 RYANODINE BINDING 
Ryanodine is a neutral alkaloid isolated from the stems of the plant Ryania speciosa 
V ahl. This plant uses the ryanodine to protect itself against insects. If the insect eats the 
bark of the plant, ryanodine causes an irreversible contraction of the insect's muscles by 
locking the release channel in an open state. As a result the intracellular Ca2+ concentration 
rises and the muscle goes into rigor. It was also shown that it has an effect in vertebrates. 
In skeletal muscle, ryanodine causes an irreversible muscle contraction and in cardiac 
muscle it lowers the contractile force. 
Tritium labeled ryanodine ([3H]ryanodine) is used in ligand binding assays. Pessah et 
al.79 demonstrated that under appropriate conditions ryanodine remained tightly bound 
with a nanomolar affinity to a single class of receptor sites on the SR. The high affinity 
ryanodine binding occurred only in the junctional SR 80, and it shows all the ligand binding 
pharmacology of the Ca2+ release channel. 79·80 Thus, ryanodine binding is stimulated in the 
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presence of adenine nucleotides, caffeine, and Ca2+, and is inhibited by Mg2+ and 
ruthenium red. This strongly indicates that ryanodine interacts directly with the Ca2+ 
release channel, and ryanodine binding is only possible if the channel is in the open state. 
In addition, ryanodine binding shows biphasic behavior at different Ca2+ concentrations. 
Binding is stimulated for > 1 µM Ca2+ and inhibited for > 1 mM Ca2+~ This correlation 
between ryanodine binding and Ca2+ -induced Ca2+ release enables us to monitor the state 
of the channel by examining the binding of [3H]ryanodine. It is believed that every 
chemical compound which changes the characteristics of ryanodine binding interacts with 
Ca2+ release channel. 
There are four ryanodine binding sites on the ryanodine receptor. They have 
different binding affinities and are described below in the order of decreasing binding 
affinity. The first, highest affinity binding site is the one which is examined in ryanodine 
binding assays and correlates with the open or closed state of the channel (l<ci::::5 nM) . The 
second binding site is responsible for the opening of the channel, and locking the channel 
into a half conductance state. The third state correlates with a quarter conductance state, 
and the lowest affinity binding site is responsible for closing down the release channel. 16a 
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1.7 THEORY AND EXPERIMENTAL TECHNIQUES OF LIGAND-
BINDING STUDIES76 
1. 7 .1 Introduction 
In organisms of higher complexity, processing information from cell to cell or from 
one subcellular unit to another is part of an informational network that the organism uses 
to maintain its integrity. The basis of this process is the recognition of chemically coded 
information by the receptor proteins that the cell expresses. The central mechanism of this 
recognition is the binding of an extracellular signaling molecule (ligand) by a receptor 
protein. The highly specific binding of the natural ligand leads to a conformational change 
within the receptor protein. This activates the receptor and leads to the subsequent 
activation of a more or less complex effector system. By integrating all intracellular 
processes, triggered by different signaling molecules, the cell responds in a way that 
normally fulfills the demand of the organism. By binding the ligand to the binding site, the 
receptor protein is activated. The triggered biological effect can be detected in vivo using 
pharmacological assays. 
Besides the pharmacological characterization of a ligand, which includes binding to 
the receptor's binding site as well as the subsequently initiated effect, the characterization 
of the binding step is a useful task. Furthermore, the examination of a receptor's binding 
properties in vitro is more easily achieved than its complete pharmacological 
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characterization. Assays for the receptor's activity or the biological effect are generally 
much more difficult. But the differentiation between specific and nonspecific binding in 
some cases is impossible without testing the biological effect coupled to it. 
The aim of binding studies is the characterization of a ligand's binding to its 
accompanying receptor. For a defined ligand/receptor pair the ligand's affinity, the rate 
constants for the ligand's binding or dissociation, the stoichiometry of binding and the 
interference of multiple binding sites on a receptor molecule, which influence one another 
during ligand binding, (i.e., the cooperativity of the binding) are characteristic parameters, 
which can be determined experimentally. 
Essential for a binding assay is the availability of a ligand that has been labeled in 
order to measure its distribution between the bound and free state. In general ligands 
labeled by radioisotopes like 3H or 1251 are used. However fluorescent labels can also be 
used. Both types of labeled ligands have to maintain the same binding characteristics as its 
nonlabeled counterpart. The main criteria for the ligand is that it has a sufficient affinity for 
the binding site and that binding times are short enough such that equilibrium occurs 
within the time scale of the assay. 
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1. 7 .2 Experimental strategies 
As a result of a binding experiment the radioligand is distributed between a bound 
and a free state. The incubation time of a binding assay depends on the experimental 
approach. Except for kinetic experiments, the incubation proceeds until equilibrium is 
established. For displacement experiments a second unlabeled ligand is added, which either 
competes with the labeled ligand for the binding sites or binds at a related site on the 
receptor. The concentration of binding sites is maintained at a constant value, while the 
ligand concentration is varied during the experiment. 
1. 7 .3 Saturation experiments 
A constant concentration of binding sites (or protein) is incubated with increasing 
concentrations of the radioligand. The incubation is continued until the equilibrium has 
been established. Then the concentrations of the free and bound radioligand are 
determined. To draw conclusions from this kind of experiment one has to assume that the 
receptor preparation contains a homogenous population of receptor protein and that the 
receptor complexes contains one or more binding sites, which bind the ligand 
independently of each other (i.e., no cooperativity occurs). Furthermore, the nonspecific 
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binding is negligible and neither receptor or ligand degradation nor isomerization of the 
receptor-ligand complex occurs during the incubation period. 
Equilibrium reaction: 
R+L~(RL) (1) 
where L stands for the free ligand, R for an unoccupied binding site, and (RL) for an 
occupied binding site in a receptor-ligand complex 
mass action law: 
[L][R] 
Kd = [(RL)] 
where ~ is the dissociation constant 
It is also known that 
[R]r = [R] + [(RL)] 
where [Rh is the total concentration of binding sites. 
(2) 
(3) 
The measured parameters, free ligand concentration F = [L] and bound ligand B = (RL) 
are used in the following discussion. Therefore 
[R] = [R]r - B (4) 
The total concentration of binding sites [Rh can also be expressed by the maximal 
concentration of ligand which is able to bind the finite number of binding sites in the assay 
volume. If the total ligand increases, the bound ligand's concentration reaches a maximal 
concentration Bmax, which equals the total concentration of binding sites [Rh. 
[R] = Bmax -B (5) 
(5) into (2) leads to 
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From 
Kd = F(Bmax - B) 
B 
B = BmaxF 
Kd +F 
(6) 
(7) 
one can see that the value of ~ equals the concentration of F at a point where B equals 
half the value of Bmax· 
A saturation experiment enables us to determine ~ and Bmax· Historically, this was 
done by the linearization of the data according to Scatchard, which allows linear 
regression analysis. Transformation of equation 7 leads to 
B -B Bmax -=-+--
F Kd Kd 
(8) 
If the ratio B/F is plotted versus B then the slope is -1/~ and the x-axis intercept is Bmax· 
If the Scatchard analysis is used for the determination of ~ and Bmax one has to 
have a minimum of 7-10 ligand concentrations. These concentrations should ideally cover 
a range of B, which is between 10 and 90% of Bmax· The occupation of binding sites 
should reach at least 80%. It is recommended to fit the line by using the data points 
between about 20 and 80% saturation of the binding sites. Furthermore, the determination 
of Bmax by using this extrapolation is based on the assumption that the simple model of 
equal and noninteracting binding sites is valid over the whole range of the ligand's 
concentration. In addition Hulme35 recommended that the optimal concentration of 
binding sites for a saturation experiment is in the range of 0.1to0.5 times the~. 
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So far only the simplest case of equal and noninteracting binding sites was 
considered. The resulting Scatchard plot gives excellent straight lines. On the other hand, 
a more complex type of binding results in a nonlinear Scatchard plot. The most obvious 
explanation for a nonlinear Scatchard plot is a cooperative interaction between binding 
sites. Binding of a ligand may cause a conformational change within the receptor protein, 
which either facilitates (positive cooperativity) or weakens (negative cooperativity) 
binding of the next ligand. Unfortunately nonlinearity can also occur because of more 
artificial causes like underestimating of the nonspecific binding, heterogeneity of binding 
sites, ligand-ligand interaction, isomerization of the receptor-ligand complex, or 
incomplete equilibration. The strength of cooperativity is described by the Hill coefficient 
nH. This constant is obtained as the slope of the linear segment of the curve resulting from 
the Hill transformation 
B 
log( ) = nH log F - nH log K0.5 (9) 
Bmax -B 
Prerequisite for this plot is the independent determination of Bmax by a saturation 
experiment. Positive cooperativity is characterized by a Hill coefficient higher than 1, 
whereas a value lower than 1 indicates negative cooperativity. The more extreme this 
value is, the stronger the cooperative interference of the binding sites. Ko.sis an integrative 
constant composed of the apparent dissociation constants of the distinct binding steps. It 
equals the free ligand's concentration at 50% saturation. If no cooperativity is seen 
(nH= 1 ), this constant is identical to ~. 
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1. 7 .4 Kinetic experiments 
Alternatively, the dissociation constant can be determined by measuring the rate 
constants k+1 for the ligand's association and k_1 for the ligand's dissociation from the 
receptor-ligand complex. In addition one can get even more information than the~ from 
this type of experiment if the ligand binding shows an unexpected behavior as a function of 
time. 
The change in the concentration of the receptor-ligand complex over time can be 
expressed as: 
d[(RL)] = k+t [R][L]- k_
1 
[(RL)] 
dt 
(10) 
In the dynamic equilibrium the association and dissociation reaction occur with the same 
rate, i.e. d[(RL)]/dt=O. From equation 10 follows 
k_1 = [R][L] = Kd 
k+1 [(RL)] 
(11) 
By the kinetic approach only the equilibrium constant can be determined and not the Bmax, 
which has to be determined by an independent saturation experiment. 
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1.7.4.1 Association rate 
For the determination of k+1, the ligand and the receptor are mixed at time t=O. The 
concentration of bound ligand B(t) is then monitored as a function of time until no further 
change occurs. The concentration of B(t) at equilibrium equals B. 
One can now determine k+1 if one assumes a pseudo-first order reaction and that the 
concentration of the free ligand F is nearly unchanged over the whole period of 
measurement and equals approximately [Lh. Therefore B should always remain below 
10% of the ligand's total concentration. With these assumptions equation 10 becomes 
dB ( t) = k 1 ( B - B ( t)) [ L] T - k _ 1 B ( t) o 2) 
dt + max 
The equation which describes the equilibrium is 
0 = k+1 (Bmax - B)[L]r - k_1B (13) 
Subtraction, separation of variables, and integration leads to 
In B -B- B(t) - (k+1 [L]r - k_1 )t = k°t (14) 
From equation (14) you can extract the apparent velocity constant k from the slope if you 
plot the logarithmic expression against time t. 
k' = k+1 [L]T -k_1 (15) 
suggests 2 possibilities to extract k+1. One method is to measure k' and determine k_1 by an 
independent experiment. The other is to measure k · for different total concentrations of 
the ligand. But the assumption that the concentration of F has to be nearly unchanged, 
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should be considered. Using this method, k+1 can be extracted from the slope and k_ 1 from 
the intercept on the y-axis. All these considerations hold only if the binding sites are 
homogenous and do not interact which each other. 
1. 7.4.2 Dissociation rate 
In dissociation one has only to consider the dissociation process. The receptor and 
the ligand are mixed and incubated until equilibrium is established. The bound ligand 
concentration equals the equilibrium concentration B. After equilibration, the association 
process is blocked either by dilution with the incubation buffer to a volume exceeding 100 
times the initial assay volume, or by strongly reducing the radioligand's specific activity by 
the addition of an excess of the unlabelled ligand. The dissociation of the radioligand is 
measured as the loss of bound radioactivity B(t) over time. The dissociation process can 
be described by 
dB(t) = -k_
1
B(t) 
dt 
Integration of this equation results in 
In B(t) = -k_1t 
B 
(16) 
(17) 
The dissociation constant k_ 1 can be extracted by the slope of the plot of the logarithm of 
B(t)/B versus time. The determination of k_1 by dilution as well as by competition with an 
excess of the nonradioactive ligand should give the same result. If not, a cooperative 
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reaction is probably involved. If the dissociation measured by dilution is faster, this might 
be caused by positive cooperativity, while a slower dissociation by dilution indicates 
negative cooperative interaction. 
1.8 o-PHTHALALDEHYDE (OPA) 
In 1971, Roth88 developed a sensitive technique for detecting of amino acids on the 
basis of their reaction with o-Phthalaldehyde. In alkaline medium in the presence of a thiol 
agent, such as 2-mercaptoethanol, a strong fluorescent signal is observed. This permits 
fluorimetric assay of amino acids down to the nanomolar range. No heating is necessary, 
and the fluorescence may easily be measured 5 min after mixing of the reagents. After ion 
exchange fractionation, amino acids can be determined automatically. A fluorescence was 
obtained with all common amino acids except cysteine, proline and hydroxyproline. A 
sharp decrease in fluorescence was observed if the buffered amino acid was first mixed 
with OP A and mercaptoethanol was added last. This indicates that in the absence of a 
reducing agent, OP A is capable of reacting otherwise with amino acids with the formation 
of nonfluorescent products. 
Simons and Johnson97 showed based on data collected from proton NMR, IR and 
mass spectral analysis of several crystallized OPA-amine-thiol derivatives that the reaction 
of OPA and 2-mercaptoethanol with primary amino acids gives a 1-alkylthio-2-
alky lisoindole product. 
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Figure 3 Mechanism for isoindole formation proposed by Simons and Johnson97 
Analyses of the chemical shifts of the isoindole alkyl substituents in the NMR spectra 
support the previous conclusions that these heterocycles have relatively low levels of 
aromatic character. The amount of isoindole formed is severely reduced by adding an 
amine to OP A before adding the thiol. The formation of this isoindole proceeds rapidly 
under mild, stoichiometric conditions and in very high yield, so there is little need for 
purification before studying the physical properties or performing further chemistry. 
Later it was found that OP A is capable of detecting picomolar quantities of amines88, 
amino acids, and proteins. 120 Of the various spectrophotometric methods currently 
available for these purposes, the OP A reaction appears to be the most sensitive 
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for amino acids.66 OPA is less efficient than other methods in detecting peptides and 
proteins66 unless the protein sulfuydryl groups are first aminoethylated. 
Simons and Johnson98 observed that when a concentration of around 100 mM OPA 
in 95% ethanol was used, the reaction is unaffected by excess thiol and in all cases 
proceeds rapidly and in ~ 90% yield, even at 0°C. In each reaction apparent maximal 
fluorescence was observed essentially immediately after adding amine. Thin layer 
chromatography analyses of the final concentrated reaction solutions revealed very little, if 
any, of the unreacted starting materials. Thiol structure has very little effect on the Aexcitation 
but the Aemission is more sensitive to structural changes of the thiol. Dilute solutions ( 10-4_ 
10-7 M) of most adducts retained ~90% of their original fluorescence after 4 days at room 
temperature in the dark. In contrast, 0.3 M solutions of 2-mercaptoethanol or ethanethiol 
adducts that were kept at room temperature in the dark for ~2 weeks and then diluted to 
3x10-7 M exhibited ::;;20% of the fluorescence of a 3xlff7 M solutions subjected to the 
same storage conditions. The monoisoindole adducts of thiols containing two SH groups 
are less stable, but even these adducts maintained ~60% fluorescence after 4 days. Very 
high concentrations (~ 10 M ) of the ethanethiol or 2-mercaptoethanol adduct are 
nonfluorescent but become fluorescent when diluted. Thus the lack of fluorescence is due 
to self-quenching rather than a concentration-dependent decomposition of the adduct. 
It was also observed that some amino acids, such as lysine and especially cysteine, 
give low to nonobservable fluorescence yields in the OP A reaction. Thus for reasons 
which are not theoretically understood, not all thiols (e.g., methyl mercaptoacetate) or 
amines necessarily give isoindoles which are intensely fluorescent. The effect of three 
45 
different solvents water, 95% ethanol, and isooctane on the spectra of the ethanethiol 
adduct was examined and it was shown that decreasing solvent polarity causes a 
progressive blue shift in the Amax which is most evident in the emission spectra. So Amax for 
the emission spectra shifts from 450 nm for water to 430 nm for 95% ethanol to 400 nm 
for isooctane. It was also seen that the presence of bulky and\or polar substituents on the 
isoindole ring appears to moderate the solvent effect on fluorescence intensity. 
The fluorescence intensity of the adducts is in general the highest for 95 % ethanol as 
the solvent, while for the two other solvents the fluorescence intensity is lower. It is the 
lowest for isooctane. The stability of the isoindole is the least stable in aqueous solution 
and the most stable in 95 % ethanol. The shape and Amax of the ethanethiol and 2-
mercaptoethanol adduct fluorescence spectra were unaffected by pH. 
In contrast, pH affects the stability of these adducts, as each adduct becomes less 
stable as the pH is lowered. DTT produces 30% less fluorescence in the OP A reaction 
than does mercaptoethanol. 16 Proteins in general have been observed to give fluorescent 
products in reactions with OPA and with and without 2-mercaptoethanol.41 ' 120 In the 
absence of 2-mercaptoethanol, the fluorescence yield of the reaction is increased by prior 
reduction of disulfide linkages to free SH groups41 , and is reduced to zero by pretreatment 
of the protein(s) with N-ethyl maleimide, which rapidly reacts with free SH groups.41 •120 
The lower fluorescence intensity and slightly different Aroax's of the GPA-protein versus 
OPA-2-mercaptoethanol-protein adducts120 could easily be due to different isoindole ring 
substituents and/or variations in the polarity of the fluorophore' s microenvironment 
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Joys and Kim43 suggest that the major reaction between OPA-2-mercaptoethanol 
adduct and peptides leading to the production of fluorescent derivatives occurred at the £-
amino group of lysine. They showed that two peptides containing C-terminal arginine 
reacted very poorly with OPA-2-mercaptoethanol whereas peptides with C-terminal lysine 
reacted very well. Moreover, as an internal residue, lysine overcame the inactivity of a C-
terminal arginine so that OP A fluorescence seemed dependent upon the presence of lysine 
and not upon the identity of the C-terminal amino acid. It was demonstrated that change in 
the N-terminal amino acid had little effect but substitution of a C-terminal arginine 
markedly increased the fluorescence. 
Experiments were carried out in which fluorescence was determined after peptides 
and OPA-2-mercaptoethanol had been mixed and allowed to stand for various times at 
room temperature or at 50°C. Fluorescence produced with all peptides was found to 
decrease with time and reached 50% of the original value after 15 min at room 
temperature. No increase in the low fluorescence produced by nonreactive peptides was 
obtained by increasing the time of contact with OPA-2-mercaptoethanol nor by heating 
the reaction mixture. 
Chen et al.25 showed that the fluorescent quantum yields of OPA derivatives of the 
naturally occurring amino acids ranged from 0.33 to 0.47 using 2-mercaptoethanol as the 
thiol compound. The fluorescent lifetimes were about 18-20 ns. Lower quantum yields 
were obtained when mercaptoethanol was replaced by dithiothreitol (DTT) or ethanethiol 
(ET). OPA is non-fluorescent until it reacts with primary amines, and any excess of 
reagent does not break down or react to form fluorescent by-products. It is therefore 
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unnecessary to separate the fluorescent products and the unreacted OPA in analytical 
procedures using these reagents. The thiol compound included in the OP A reaction was 
originally thought to function simply as a reducing agent, but Simons and Johnson97a 
showed that the thiol actually becomes part of the final product. The absorption 
spectral properties of the OPA -mercaptoethanol and GPA-alanine complexes are 
clearly distinct from those of the fluorescent product OPA-mercaptoethanol-alanine 
(figure 4). 
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Figure 4 Absorption spectra of OPA and its derivatives. The soJid curves were obtained with 
solutions containing 0.05 M sodium borate buffer, pH 9.0 and combinations of 3.3 10·3 M OPA, 
4.8 10·2 M ME, and 5 10·3 M alanine. From right to left, the solid lines are spectra of solutions 
containing OP A + alanine, OP A alone, OP A + ME, and ME alone. The dotted curve represents 
a fluorescent solution of OPA(ME)-alanine formed in a solution containing 0.01 M sodium 
borate, pH 9.0, 1.3 10·4 M alanine, 10·2 MME, and 6.7 10·4 M OPA.25 
Figure 5 The interaction of ME with OP A. Each solution contained 0.033 M sodium borate, 
pH 9.0, 3.3 10·3 M OPA. The absorbance at 300 nm (0) or the absorbance at 334 nm (D) in the 
presence of 3.3 10·3 M alanine was followed as a function of the molar ratio of added ME.25 
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Examination of the amount of mercaptoethanol required for optimum fluorescence 
yield showed that approximately 2 moles mercaptoethanol/mole of OPA yield the 
maximum amount of fluorescent product, which absorbs at 334 nm. As a result of 
formation of this fluorescent product there is a corresponding reduction in the absorbance 
of OPA at 299 nm. 
The stability of OP A products was noted to be affected by both the thiol and the 
amine involved. The fact that peptides yield a small fluorescence was shown to be due to a 
low quantum yield rather than low reactivity. The fluorescent products obtained with 
OPA-ET and OPA-DTT had lower quantum yields and shorter lifetimes than those of 
OPA-ME. They also appear to be more stable than those using ME. The reaction of 
OPA-ME with alanine is blocked by adding cysteine before alanine. If cysteine is added 
after alanine is added to OP A-ME, there is little if any reversal of the fluorogenic reaction. 
An increase in temperature decreases the fluorescence yield. It had previously been 
shown88 that an alkaline pH favors the OPA fluorogenic reaction, but a high pH is also 
needed to observe the fluorescence of the formed products. DMSO enhances the stability 
of the OPA product. The instability of these compounds was attributed by Simons and 
Johnson97 to an intramolecular nucleophilic attack by the hydroxyl group of the ME 
moiety, and this is evidently prevented by 60% DMSO. 
Recently6, N-acetyl-L-cysteine (NAC) has been substituted for 2-mercaptoethanol in 
the pre- and postcolumn OPA-derivatization of primary amines and amino acids with good 
results. The fluorescence of OPA-NAC derivatives is nearly identical to that of the OPA-
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2-mercaptoethanol products. This reaction is rapid, and the NAC derivatives are more 
stable than either 2-mercaptoethanol or ethanethiol derivatives. 
Puri et al. 83 used OP A to label a catalytic subunit from bovine skeletal muscle. 
They showed that OPA decreases the activity of the labeled enzyme. It was shown that 
the reaction between the catalytic subunit and OP A was not reversed by the addition of 
reagents containing free primary amino and sulfhydryl functions following inactivation. 
The reaction, however, could be arrested at any stage during its progress by the 
addition of an excess of cysteine or less efficiently by homocysteine or glutathione. 
It is therefore reasonable to assume that the proximity of SH function of the 
cysteine residue and £-NH2 function of the lysine residue in the C-subunit participating 
in reaction with OP A is comparable to that of SH and NH2 functions in cysteine and the 
distance between the two CHO functions in OPA which is around 0.3 nm. They also 
suggested the reaction scheme of the OPA-C-subunit reaction. 
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Figure 6 Schematic representation of the reaction between the C subunit of an enzyme and 
OPA83 
50 
The conversion of intermediate c to the isoindole derivative d is thermodynamically 
favorable since such a process converts the benzenoid ring of OP A, a six overlapping 1t-
electron system to an isoindole ring system, a ten overlapping 1t-electron system. The 
reaction between C-subunit and OPA is irreversible and the isoindole derivative formed is 
stable under the experimental conditions over a period of at least 24 hours. 
Spectrofluorometric examination of the reaction mixtures containing synthetic 
peptides (NH2 function donors) and OPA in the presence or absence of 2-mercaptoethanol 
(SH function donor) did not show the formation of isoindole derivative. The results of 
these investigations suggest that only the E-NH2 function provided by a lysine residue (and 
not the secondary amino or primary amino functions of histidine or arginine, respectively) 
participates in an isoindole derivative formation in the reaction between the C subunit and 
OPA.83 
The aim of this thesis is to examine the interaction between OP A and the Ca2+ 
release channel. The motivation for using OPA comes from its ability to react with a 
cysteine and a lysine at the same time to form an isoindole derivative. Therefore, the 
possible proximity of a lysine residue on the Ca2+ release channel to a critical sulthydryl 
residue was examined. 
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CHAPTER II 
2 METHODS AND MATERIALS 
2.1 SR PREPARATION 
SR vesicles were isolated according to the methods of MacLennan.55 Fast (white) 
muscles from the back and the hind legs of a New Zealand White rabbit were used. The fat 
and the connective tissues were trimmed off. The muscles are quickly ground in a meat 
grinder and added to buffer A (120 mM NaCl, 10 mM imidazole, 100 µM dithiothreitol 
(DTT), pH 7.4). The ground muscle is homogenized in a blender alternating low and high 
speed for 15 and 30 seconds respectively (four times). The resulting solution was then 
centrifuged at 1600xg (3100 rotations per minute (rpm) in the large Sorvall GSA rotor) 
for ten minutes. The final supernatant fraction is filtered through four layers of cheesecloth 
and adjusted to pH 7.4 with dry imidazole. The pelleted cell debris was discarded. Next, 
the filtrate is centrifuged at 10,000xg ( 8000 rpm in the GSA rotor) for 14 minutes. The 
supernatant was filtered through four layers of cheesecloth and the brown pellet which is 
composed off mitochondria primarily, was discarded. The suspension was then 
ultracentrifuged at 44,000xg ( 19,000 rpm in the Beckman type 19 rotor) for 70 minutes 
and the supernatant was discarded. The pellet was resuspended at about 10 mg/mL in 
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buffer A, and homogenized with a glass homogenizer. This solution was then centrifuged 
at 7500xg (11,000 rpm in the Beckman Ti60 rotor) for 10 min., to pellet myosin. The 
myosin pellet was discarded and the supernatant was centrifuged at 78,000xg ( 35,000 
rpm, still in Ti60 rotor) for 30 minutes. The supernatant was discarded while the SR pellet 
was suspended into a buffer B ( 100 mM KCl, 20 mM Hepes, pH 7 .0) at a final 
concentration at about 25mg/mL. 
The SR suspension was stored in small aliquots in liquid nitrogen. The final protein 
concentration was determined by spectroscopy45 ·> as described below. 
2.2 CHEMICALS 
OP A with purity ~99% was purchased from Sigma. The molecular weight of the 
OPA is 134.1 g/mol. OPA solutions were always prepared freshly in DMSO. Although 
OP A can be dissolved in ethanol, in control experiments it was shown that ethanol by itself 
caused Ca2+ release from SR vesicles and this release was inhibited by ruthenium red. 
Therefore, in all experiments, OPA was dissolved in DMSO. SR vesicles were less 
sensitive to DMSO. At the concentrations used no adverse effects of DMSO were 
observed. Since OP A is known to be light sensitive, OP A was shielded from ambient light. 
Mg-ATP was stored in liquid N2, A23187 and ryanodine were stored in the 
refrigerator, and CaCh and EGTA were stored at room temperature. All these reagents 
were purchased from Sigma. 
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2.3 DETERMINATION OF THE PROTEIN CONCENTRATION 
Protein concentration was measured by absorption spectroscopy. A cuvette with 
900 mL H20 and 100 mL of 10% sodium dodecyl sulfate (SDS) was placed in a 
spectrophotometer and calibrated. Subsequently, 10 µl of the unknown protein sample 
was added to the cuvette and the absorbance at 230 nm, 260 nm, and 280 nm was 
measured three times in triplicate with a Beckman DU-7 spectrophotometer. The final 
protein concentration was determined according to the method of Kalckar.45 
Most proteins show one distinct absorption maximum at 280 nm, due primarily to 
the presence of tyrosine and tryptophan. The backbone of the peptide bond absorbs at 230 
nm. The method uses those absorption characteristics as a tool to determine the protein 
concentration, while also considering a possible contamination of nucleic acids which 
absorb most strongly at 260 nm. 
Protein concentration (mg/mL) = 100 (1.45 Abs2so - 0.74 Abs26o) 
Protein concentration (mg/mL) = 100 (0.183 Abs23o - 0.075 Abs260) 
From all three measurements and both equations the average value was determined. 
This procedure was repeated and the final concentration was calculated from the average 
of the two determined concentrations and expressed as mean protein concentration ± 
standard deviation. 
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2.4 [3H]RYANODINE BINDING STUDIES 
For all [3H]ryanodine binding studies, the methods described by Pessah 80 were used. 
[3H]ryanodine had a specific activity of 76.2 Ci/mmol and was purchased from Du Pont. 
SR vesicles (0.5 mg/mL) were incubated at 37°C for 3 h in a medium containing 250 mM 
KCl, 15 mM NaCl, 50 µM CaCh, 20 mM Hepes, pH 7.1, 14 nM ryanodine, and 1 nM 
[3H]ryanodine. Depending on the desired conditions of the assay various concentrations of 
OP A or other Ca2+ channel modulators were present during the incubation. 
Assays were terminated by rapid filtration through Whatman GF/B glass fiber filters 
in a cell harvester (Brandel, Gaithersburg, MD) and by washing of the filters with a 3 mL 
solution containing 250 mM KCl, 15 mM NaCl, 20 mM Hepes, pH 7.1 , and 50 µM 
CaCh. The washing process was repeated three times. Subsequently, the filters were 
placed into scintillation vials, incubated with 2.5 mL of scintillation fluid (Beckman, 
ReadySafe) and shaken overnight. The efficiency of the scintillation fluid was around 53%. 
Nonspecific ryanodine binding was determined by measuring binding following the 
addition of 2 mM EGT A which decreased the free Ca2+ concentration to about 16 nM or 
by adding a 100 fold excess of unlabeled ryanodine. 
55 
2.4.1 Measurements of association kinetics 
The association rate of [3H]ryanodine binding was determined over a time range of 5 
to 240 minutes. The experiment was carried out at several different OP A concentrations. 
OP A was added to the solution of 0.5mg/mL SR vesicles in the buffer of 250 mM KCl, 15 
mM NaCl, 50 µM CaCh, 20 mM Hepes, pH 7.1, 14 nM ryanodine, and 1 nM 
[3H]ryanodine. At each OP A concentration samples were incubated in a 37°C waterbath 
for varying periods of time. They were then transferred to an ice bath, and filtered through 
GF/B filters. Nonspecific binding was determined by the addition of 2 mM EGT A and was 
measured for different incubation times, varying from 15 mins to 4 hours. Almost no 
variation could be observed in non-specific binding as a function of time. As a control we 
showed that the binding after 4 hours on ice was almost exactly as high as nonspecific 
binding. In other words there was negligible binding to the high affinity ryanodine binding 
sites when the sample was incubated on ice over the time course of the experiment. 
2.4.2 Measurements of dissociation kinetics 
The purpose of this experiment was to determine the dissociation rate constant by 
measuring the time dependence of dissociation of the equilibrated [3H]ryanodine-protein 
complex in the presence of different OPA concentrations. SR vesicles (5mg/mL) were 
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incubated in a solution of 250 mM KCl, 15 mM NaCl, 50 µM CaCh, 20 mM Hepes, pH 
7 .1, and 10 nM [3H]ryanodine for 3 hours in 37°C and then diluted by a factor of 100 into 
an identical buffer containing various OP A concentrations with no [3H]ryanodine present. 
These diluted solutions were put on ice to prevent dissociation. As a control showed, even 
after 3 hours on ice only a negligible amount of [3H]ryanodine had dissociated from its 
receptor binding site. The dissociation experiment was done for time steps between 5 and 
180 minutes and was set up such that all samples were filtered at the same time. To start 
the dissociation experiment the already diluted solution was taken out of the beaker on ice 
and was incubated in 37°C for the appropriate time. The nonspecific binding was 
determined by addition of 2 mM EGT A to the concentrated solution for 3 hours in 37°C. 
2.5 MEASUREMENTS OF CALCIUM EFFLUX 
Ca2+ fluxes were monitored using a dual wavelength spectrophotometer by 
measuring the differential absorption changes of antipyrylazo III [bis( 4-antipyrylazo )-4,5-
dihydroxy-2,7-naphthalenedisulfonic acid] at 720-790 nm. The presence of Ca2+ causes a 
marked increase in absorbance of antipyrylazo III in the spectral area between 660 and 
800 nm. At the same wavelengths Mg2+ and Mn2+ are without effect and also the 
absorption of other divalent ions, which are often present in cell or cell fractions, is very 
low. Therefore, interference by other ions does not lead to artifactual readings. 
Antipyrylazo neither binds to cell fractions nor affects cellular properties. In a buffered 
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reaction mixture at pH 7 containing 100 mM KCl, the antipyrylazo-calcium complex has a 
~ of 120 µM and a relaxation time of 180 µsec. It is mostly suitable for measurements at 
concentrations of Ca2+ ranging from 1 to 100 µM, where it has adequate sensitivity 
without compromising calibration linearity or disturbing the free Ca2+ in the system.95a 
The measuring of differential absorption changes is accomplished using a dual 
wavelength spectrophotometer with a time resolution of ::::: 10 ms. Interference filters allow 
the transmission of light of wavelengths of 720 nm and 790 nm. A continious monitor of 
the absorbance difference between these two wavelengths is proportional to the free Ca2+ 
concentration in the extravesicular space. 
Ca2+ uptake into SR vesicles (0.2mg/mL) was carried out in a buffer containing 100 
mM KCl, 20 mM Hepes, pH 7.0, 1 mM MgCh, and 200 µM antipyrylazo III. The final 
volume was 1.5 mL. During the entire experiment, the extravesicular Ca2+ concentration 
was recorded as a function of time on a x-y printer. Following the addition of SR to the 
cuvette with the described buffer, 15 µM CaCh was added. After equilibration of the 
antipyrylazo-calcium complex, 0.5 mM Mg-ATP was added to stimulate the Ca2+ uptake 
into the vesicles. Release was initiated by adding the OP A following the completion of 
Ca2+ uptake. Ca2+ efflux rates were determined from the maximal slope of the 
extravesicular Ca2+ versus time. At the end of some experiments the Ca2+ ionophore 
A23187 was added to the cuvette to determine the Ca2+ remaining in the SR vesicles 
following the release with OP A. After adding the A23187, the extravesicular Ca2+ 
concentration should return to the same level it was before the addition of Mg-ATP. The 
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OPA concentrations ranged from 20 µM to 12 mM. For each concentration at least three 
experiments were done and the average value of the release rate was reported. 
Experiments with ruthenium red were carried out to determine if OP A induced 
release occured via interaction with the SR Ca2+ release channel . The experiments were 
performed as described in the above section with the only difference that ruthenium red 
was added prior to the addition of OP A. Experiments with ruthenium red in the range 
between 0.25 and 10 µM were carried out in triplicate and in the range between 20 and 90 
µM in duplicate. 
All transport assays were done with the same SR preparation. Ca2+ uptake did not 
vary by more than 5% from one experiment to the next. 
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CHAPTER III 
3 SPECTROPHOTOMETRIC ASSAY OF CALCIUM EFFLUX 
In this section, the ability of OP A in stimulating Ca2+ release from SR vesicles is 
examined. This assay was done with the spectrophotometer as described above. As a 
control, the possible effect of DMSO causing Ca2+ release by interacting with the Ca2+ 
release channel or the membrane was examined. Addition of different concentrations of 
DMSO showed that up to 2 % DMSO of the final solution did not cause any Ca2+ release 
after 5 minutes. In all subsequent experiments, the final DMSO concentration did not 
exceed 2%. 
3.1 OPA STIMULATED CALCIUM RELEASE 
In these experiments OP A concentrations ranging from 20 µM to 12 mM were used. 
It was observed that OPA stimulates Ca2+ release in a concentration dependent manner. 
A maximal release rate of approximately 27 nmol/mg/sec was obtained at 12mM. A 
linear relationship between the release rate and the OP A concentration was seen at low 
OP A concentrations. For higher concentrations the slope of the graph decreases indicating 
that the release rate approaches saturation. The release rate at high concentrations of OP A 
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Figure 7 
Ca2+ release rate from SR vesicles as a function of OP A concentration. The release rate is 
computed from the maximal slope of Ca2+ concentration versus time and normalized to the 
number of milligrams of SR. SR vesicles are suspended in 100 mM KCL, 1 mM MgCh, 20 
mM HEPES, pH 7.0, 200 µMAP III, and 15 µM CaCh at a protein concentration of 0.2 
mg/ml. 0.5 mM MgATP was added to stimulate the Ca2+ uptake. Extravesicular free Ca2+ 
concentration is recorded spectrophotometrically by measuring the differential absorbance 
of AP III at 720 nm and 790 nm. At the end of each experiment, the ionophore A23187 
was added to release intravesicular free Ca2+. Each point represents the average of at least 
three measurements. The error bars indicate the standard deviation. 
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began to approach the limits of instrumentation. Hence, no data at OP A concentrations 
greater than 12 mM were taken. It was also observed that for concentrations of OP A 
higher than 1 mM all of Ca2+ was released from the vesicles. No additional Ca2+ was 
released from the vesicles when the Ca2+ ionophore A23187 was added to the cuvette. 
3.2 INHIBITION OF CALCIUM RELEASE BY RUTHENIUM RED 
In Figure 7 it was shown that OP A can stimulate Ca2+ release from SR vesicles. 
However, it is not clear if this release is due to a nonspecific interaction between OPA and 
the SR vesicles. Also OPA could interact with the Ca2+-Mg2+-ATPase by inhibiting its 
ability to pump Ca2+ into the SR vesicles. Inhibition of the Ca2+ pump could also lead to 
Ca2+ release, because in order to maintain the Ca2+ gradient across the SR, an active pump 
is required. In the absence of a functioning pump, a slow leakage of Ca2+ across the SR 
would deplete internal Ca2+ stores. Alternatively, OPA might interact with the lipid 
bilayers and damage the integity of the lipid membrane. To determine wether OPA was 
interacting with the Ca2+ release channel, experiments were carried out with the channel 
inhibitor ruthenium red. 
The ruthenium red concentration was varied from 0.25 µM to 90 µM. Figure 8 
clearly shows that ruthenium red inhibits the stimulation of Ca2+ release by 1 mM OP A. 
The K1 was approx. 3.8 µM (i.e., at a ruthenium red concentration of 3.8 µM, the release 
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rate is half of the maximal release rate at 0 µM ruthenium red). This result indicates that 
OP A interacts specifically with the Ca2+ release channel as ruthenium red is known to 
interact specifically with the Ca2+ release channel. However, this does not exclude an 
additional interaction with the Ca2+-Mg2+-ATPase. 
Since it is known that adenosine nucleotides, like Mg-ATP, enhance Ca2+ release 
rates caused by other channel activators, acetylphosphate, a non-adenine nucleotide 
substrate, was used instead of the Mg-ATP to load the SR vesicles with Ca2+. A release 
rate, which was approx. 20% smaller, was observed (data not shown), indicating that OPA 
stimulated Ca2+ release is enhanced when Mg-ATP is used for the uptake. 
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Ca2+ release rate as a function of ruthenium red concentration. SR vesicles are treated as 
described in Figure 7. The ruthenium red was added after the Ca2+ uptake was complete. 
Then 1 mM OP A was added, and the Ca2+ release was recorded and the Ca2+ release rate 
computed as described in Figure 7. In the range between 0.25 µM and 10 µM ruthenium 
red, each point is the average of at least 3 measurements, while between 20 µM and 90 
µM each point is the average of 2 measurements. The error bars indicate the standard 
deviations. 
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CHAPTER IV 
4 RY ANODINE BINDING ASSAYS 
4.1 OPA STIMULATED RYANODINE BINDING 
Ryanodine binding as a function of OPA concentrations revealed a biphasic behavior 
(Figure 9). Low concentrations of OPA stimulate ryanodine binding by a factor up to 2, 
while higher concentrations completely inhibited the binding. The concentration 
dependence is relatively sharp (i.e., the stimulation and inhibition of the binding occurs 
over a range of about 200 µM OPA). In all of these experiments and in all following ones 
only 1 % DMSO was present in each test tube. It was shown that 1 % DMSO has a 
negligible effect on the ryanodine binding. This biphasic behavior was observed in more 
than 8 different experiments with 6 different SR preparations. The only difference which 
was seen is that the peak was shifted a little bit and the factor of stimulation varied if a 
new SR preparation was used. Figure 9 shows a representative curve. 
This biphasic binding behavior indicates that there are at least two different binding 
sites for OP A on the ryanodine receptor. Binding to the high affinity binding site 
stimulates ryanodine binding and binding to the low affinity binding site inhibits ryanodine 
binding. This is likely to correlate with opening and closing of the release channel and 
should be further examined in single channel reconstitution experiments. 
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[3H]ryanodine binding as a function of OPA concentration. SR vesicles (0.5 mg/mL) were 
incubated at 37°C for 3 hours in a medium containing 250 mM KCL, 15 mM NaCl, 50 
µM CaCh, 20 mM HEPES, pH 7.1, 14 nM Ryanodine, 1 nM [3H]ryanodine, and the 
indicated OP A concentration. Assays were terminated by rapid filtration through 
Whatman GF/B glass fiber filters in a cell harvester and filters were then washed 3 times 
with a 3 mL solution containing 250 mM KCL, 15 mM NaCl, 20 mM HEPES, pH 7.1, 
and 50 µM CaCh. Filters sat overnight in 2.5 mL scintillation fluid and the bound 
[3H]Ryanodine was measured in a scintillation counter. Nonspecific binding was 
determined at 16 nM free Ca2+ concentration. 
66 
4.2 ASSOCIATION EXPERIMENT 
Since the previous assay measures ryanodine binding only after 3 hours, an 
association experiment, where ryanodine binding was measured as a function of time, was 
performed and is shown in Figure 10. In Figure 10, we observe that ryanodine binding 
stimulated by OPA is dependent of both time and concentration. The control experiment 
with no OPA shows almost complete saturation after 3 hours. Low OPA concentrations 
show a similar time dependent behavior as does the control. On the other hand, higher 
OPA concentrations show a biphasic time dependent behavior. First ryanodine binding 
increases as a function of time, followed by decreasing to zero after a longer period of 
time. The debinding phase starts after approximately 30 min for all OPA concentrations 
that exhibit debinding behavior. We also observe that OP A at all concentrations enhances 
the initial rate at which ryanodine binds. 
At 3 hours, the binding of ryanodine at higher OP A concentrations has increased 
and subsequently decreased, leading to the observed biphasic shape observed in Figure 9. 
This time dependence of ryanodine binding was observed 3 times for three different SR 
preparations. The only difference observed between different SR preparations was a slight 
change in the sensitivity to OP A. It is not yet known why the decreasing phase, which 
probably corresponds to the binding of OPA to a low affinity binding site on the receptor, 
is so slow in inactivating the receptor ( ~30 min). 
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[3H]ryanodine binding as a function of time. This assay was performed as described in 
Figure 9 with the only difference that the SR was incubated for the indicated amount of 
time in the 37°C waterbath. Nonspecific binding was determined at 16 nM free Ca2+ and 
was time-independent. 
68 
5 
I I I - /I • control 
• 90µM OPA 
41 I 7 / I .. 180µM OPA 
... 270µM OPA - 3 --co I I I / I• 400µM OPA I 
~ ......... 
co c - 2 
0 ~--~~~~---~~~~~~~-----.~~---.-~~--
0 20 40 60 80 100 120 140 
time (min) 
Figure 11 
The logarithm of the ratio: Bmaxl(Bmax-B(t)) as a function of time. Bmax is the maximal 
ryanodine binding from Figure 10 for each OPA concentration, respectively. B(t) is the 
bound ryanodine at the indicate time in Figure 10. This graph is derived from data shown 
in Figure 10. The slope of the line shown represents the observed binding constant k'. 
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From the observed binding rate, the association rate constant k+1 can be extracted as 
described in chapter 2.4.1, if the dissociation rate k1 is known. Therefore the dissociation 
rate k_1 has to be determined in an independent experiment. The observed binding rate (see 
Table 1) at each OP A concentration is the slope of the lines shown in Figure 11 (equation 
14). 
Table 1 
OPA [µM] k' [-1-. ] 
mm 
·o 0.018 
90 0.037 
180 0.066 
270 0.11 
400 0.18 
4.3 DISSOCIATION EXPERIMENTS 
This assay shows the time dependence of ryanodine dissociation in the presence of 
different OPA concentrations (Figure 12). If the logarithm of the ratio of bound ryanodine 
at time t and the bound ryanodine at time t=O is plotted against the time (Figure 13), the 
dissociation rate k_1 can be extracted from the slope (equation 17). For all OPA 
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Figure 12 
[3H]ryanodine dissociation as a function of time. SR vesicles (5 mg/mL) were incubated in 
a solution of 250 mM KCL, 15 nmM NaCl, 50 µM CaCh, 20 mM HEPES, pH 7.1, and 
10 nM [3H]ryanodine for 3 hours in 37°C. Samples were then diluted 100 times into an 
identical buffer in the presence of the indcated OP A concentration with no [3H]ryanodine 
present. Following the indicated time in the dilution buffer, the sample was filtered, 
washed, and counted as described in Figure 9. Nonspecific binding was determined at 16 
nM free Ca2+ in the concentrated solution after 3 hours in 37°C. 
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Figure 13 
Logarithm of B(t)/B(O) as a function of time. This graph is derived from the same data 
shown in Figure 12, only transformed so that the dissociation constant k_1 can be 
determined from the slope of the linear regression lines. 
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concentrations data points at a time longer than 30 minutes weren't considered. At a 
concentration of 90 µM OP A, the dissociation rate is slightly slower than the control ( 0 
µM OPA), while for higher OPA concentrations the dissociation rate increases with 
increasing OP A concentrations (Table 2). 
Table 2 
OPA [µM] 1 Dissociation rate k_i [-. ] 
nun 
0 0.033 
90 0.025 
180 0.056 
220 0.078 
-
270 0.11 
400 0.13 
Having calculated the dissociation rate constant k_1 the association rate constant 
k+1 can now be calculated (equation 15). In addition, the equilibrium dissociation constant 
Ket can also be calculated (equation 11). 
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Table 3 
OPA [µM] 1 ~[nM] 
k+i [ . M] mmxµ 
0 0.003 11 
90 0.004 6.3 
180 0.008 7.0 
270 0.014 7.9 
400 0.021 6.4 
Table 3 demonstrates that the association rate constant k+1 for ryanodine binding increases 
with increasing OP A concentrations. But the dissociation constant Kci, is only slightly 
dependent on the OPA concentration. The affinity of the receptor for ryanodine increases 
slightly as the OP A concentration increases. 
4.4 SCATCHARD-ANAL YSIS 
Scatchard analysis provides for an independent determination of the Kci. In addition, 
the maximal number of high affinity ryanodine binding sites, Bmax, can be determined. SR 
vesicles were incubated in ryanodine concentrations from 0.5 nM to 128 nM for 3 hours at 
37°C. The nonspecific binding was determined by incubating SR in a 255 fold excess of 
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Saturation binding. The SR vesicles were treated as described in Figure 9 except that 
different concentrations of ryanodine were present. The [3H]ryanodine concentration was 
held constant at 0.5 nM, while the ryanodine concentration was varied from 0 nM to 127.5 
nM. Nonspecific binding was determined with a 255-fold excess of the unlabeled 
ryanodine for each OP A concentration. 
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unlabelled ryanodine. In Figure 14, the bound ryanodine is plotted against the added 
concentration of ryanodine in the assay. For the control, 180 µM, and 220 µM the binding 
saturates with increasing ryanodine concentrations. One can clearly see that the initial 
slope is much higher in the presence of OP A and that the maximal binding for 180 µM is 
increased by a factor of almost 3, while for the control and 220 µM the maximal binding is 
nearly the same. 
These binding characteristics can be quantified in a more precise manner with a 
Scatchard plot analysis of the binding data (Figure 15) as described in chapter 1. 7 .3. This 
analysis shows that the ~ for 180 µM and 220 µM OP A is decreased by a factor of 
approx. 4, in comparison with the ~ measured in the absence of OP A. The number of 
maximal binding sites Bmax for 180 µM OP A is approximately 2.5 times higher than for the 
control and for 220 µM OP A. In addition, it appears that OP A does not induce 
cooperativity in the ryanodine binding characteristics. 
This characteristic change in the ~ and in the maximal number of binding sites Bmax 
can help explain the biphasic shape of Figure 15. OPA increases the affinity for ryanodine 
binding which results in an increase of ryanodine binding for concentrations up to 180 µM 
OP A. Also, the number of maximal binding sites is increased. At 220 µM, which is in the 
falling phase of Figure 9, the affinity for ryanodine binding is the same as for 180 µM, but 
the number of maximal binding decreases to that of the control. Since it is known that for 
each ryanodine receptor complex, which consists of four identical subunits, there is only 
one high affinity ryanodine binding site, the increase of Bmax in the presence of 180 µM 
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Figure 15 
Scatchard analysis of the binding data from Figure 14. A linear regression was applied to 
the data points. The slope is the negative dissociation constant -~ and the x-intersection 
is the maximum number of high affinity binding sites Bmax· 
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OPA must be caused by an opening of more ryanodine receptor/Ca2+ channels than 
are available in the open state in the presence of 50 µM Ca2+. 
Table 4 
OPA [µM] Kct [nM] Bmax [prnol/rng] 
0 16 5.4 
180 4.0 13 
220 4.4 6.1 
The values of the ~ obtained from the Scatchard analysis (Table 4) are different than 
those obtained from the kinetic analysis (Table 3). One possible reason is that different 
SR preparations were used in the two experiments. This may explain the difference for the 
Kct between the control and also for 180 µM OPA in the two experiments. However, the 
effect is still the same, that the ~ is lowered by the OP A independently of the 
concentration. Yet, the two different ~' s for ryanodine binding in the presence of 220 
µM can't be compared, because in the kinetic approach, only binding of OPA to the high 
affinity binding site is considered. However, in the Scatchard analysis OPA binding to both 
the high and low affinity binding site is involved. Nevertheless, the Scatchard analysis 
shows that the Kct doesn't change if OPA binds additionally to the low affinity binding site. 
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4.5 CALCIUM-DEPENDENT RY ANODINE BINDING 
4.5.1 OP A Dependence 
This assay examines the effect of OP A on the calcium dependent ryanodine binding. 
Nonspecific binding was determined at 10 nM Ca2+ in the absence of OP A. Experiments 
with a 255 fold excess of unlabelled ryanodine in the presence of different OPA 
concentrations showed that the nonspecific binding is almost independent of the OP A 
concentration. Therefore, the same nonspecific binding was subtracted off at all OPA 
concentrations. Figure 16 shows the Ca2+ dependence of ryanodine binding at several 
different OPA concentrations. OP A does not affect the Ca2+ concentration required to 
stimulate or inhibit ryanodine binding. Stimulation of binding begins at approx. 0.1 µM 
Ca2+, while inhibition of binding occurs at greater than 50-100 µM Ca2+. It appears that 
OPA influences ryanodine binding independent of Ca2+, which results in a biphasic binding 
behavior for each free Ca2+ concentration. Stimulation of ryanodine binding by OPA is 
Ca2+ independent. 
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Figure 16 
[3H]ryanodine binding as a function of free Ca2+ concentration in the presence of different 
OP A comcentrations. The SR vesicles are treated as described in Figure 9 with the 
exception that the free Ca2+ concentration was varied from 10 nM to 3 mM. Nonspecific 
binding was determined at 10 nM Ca2+ without OP A. 
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4.5.2 Time Dependence 
The previous experiments suggested that the effect of OP A on ryanodine binding is 
both time and concentration dependent. Therefore, Ca2+ -dependent ryanodine binding was 
measured in the presence of 220 µM OP A as a function of time. In the control experiment 
shown, SR was incubated for 3 hours in the presence of 220 µM OP A. The assay was 
carried out as described in Figure 9, however, the reaction was terminated at various 
between 10 and 100 minutes. As in Figure 16, Figure 17 shows that OP A modification of 
ryanodine binding is Ca2+ independent. 
4.6 DTT DEPENDENT RYANODINE BINDING 
Dithiotreitol (DTT) is a reducing agent which is cable of reducing disulfide linkages. 
As shown in Figure 18, DTT alone lowers ryanodine binding in the presence of 50 µM 
Ca2+. DTT apparently reduces disulfide linkages formed by activation with Ca2+ and at 
least partially closes the Ca2+ release channel. As a result, ryanodine binding decreases as a 
function of increasing DTT concentrations. At higher concentrations (> 1 OmM), DTT 
again stimulates ryanodine binding. Experiments with H20 2, which stimulates ryanodine 
binding by oxidizing two sulfhydryl groups to disulfides30a, show that DTT is potent in 
inhibiting ryanodine binding of SR vesicles pretreated with 1 mM H20 2• In Figure 16, SR 
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Figure 17 
[3H]ryanodine binding as a function of free Ca2+ concentrations in the presence of 220 µM 
OPA. The SR was treated as in Figure 16 except that binding was terminated at the time 
indicated. Nonspecific binding was determined at 10 nM Ca2+ without OP A. The control 
binding was stopped after 3 hours. 
82 
?---~~~~~~~~~~~~~~~~~~~ 
6 'II"' -- ----- __..._'II 
'@ 
E 5 -0 
E 
/ " · - · '----· • 90µM OPA -9: 
"C 
c 
~ 
0 
Q) 
Q) 
c =a 
0 
c 
<tS 
4 
3 
~ 2 
I' 
C'L,., 
o--~~---.~~~-.-~~~..--~~---r-~~~-r--" 
0.0010 0.0100 0.1000 1.0000 10.0000 100.0000 
OTT [mM] 
Figure 18 
• control 
[3H]ryanodine binding as a function of DTT. The SR was incubated for 15 minutes with 
90 µM OPA before it was added to the DTT. Nonspecific binding was determined at 16 
nM free Ca2+. 
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vesicles were pretreated with 90 µM OPA for 15 minutes, then DTT dependent ryanodine 
binding was examined. 
OP A stimulated ryanodine binding is not exhibited by addition of DTT. Small 
variations in ryanodine binding are observed, but significant inhibition by DTT is not 
apparent. This suggests that OP A stimulates receptor binding by a direct interaction. 
There is no indirect mechanism, such as binding of OP A to one site on the receptor, 
resulting in activation of the channel by causing a disulfide linkage to occur. If this had 
been the case, DTT would reduce the disulfide and inhibit the activation induced by OP A. 
4.7 LYSINE-DEPENDENT RYANODINE BINDING 
OP A reacts with a thiol and a nearby lysine. In order to examine if both binding sites 
are important for channel activation, OPA was pretreated with lysine. The motivation 
behind this experiment is that if OP A is pretreated with an excess of lysine it should than 
freely react with protein thiols, and should no longer favor protein thiols that are nearby a 
lysine residue. In Figure 19, 90 µM OP A was incubated for 10 minutes with different 
concentrations of lysine. This binding assay was done at 50 µM Ca2+ for 3 hours at 37°C. 
As the ratio of lysine/OP A is increased, ryanodine binding decreased to a point 
slightly higher than the control binding, (i.e., the same conditions but without OPA and 
lysine). There are several possible interpretations for this result. One possible explanation 
is that the GPA-lysine complex is still able to react with free thiols, but most of these 
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thiols are not critical to channel function. Alternatively the OPA-lysine complex may no 
longer be able to react with free critical thiols. In the absence of added lysine, OP A binds 
to a pair of amino acids ( cysteine-lysine) that are nearby each other, and critical for 
channel function. 
4.8 COMPETITION BETWEEN OPA AND CPM 
In this binding assay the ability of OP A to stimulate ryanodine binding to a CPM 
pretreated RyR was examined. The purpose of this experiment is to see if OPA and CPM 
have a common binding site on the RyR. 
In order to pretreat the SR vesicles with CPM, the free Ca2+ concentration was 
first lowered to 16 nM to close the Ca2+ release mechanism and to expose "hyperreactive 
thiols".52 CPM (0.5 µM) was then added to the SR for 5 minutes at 37°C. It has 
previously been shown that this concentration of CPM is optimal for alkylating key 
hyperreactive thiols associated with channel gating. The free Ca2+ concentration was then 
returned to 50 µMand OPA dependent [3H]ryanodine binding was measured (Figure 20). 
In the control experiment identical procedures were followed, but the SR was not treated 
with CPM. Also, at 90 µM and 180 µM OPA, the experiment with and without CPM was 
carried out at a free Ca2+ concentration of 16 nM. 
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[3H]ryanodine binding in the presence of 90 µM OP A and an excess of lysine. A mixture 
of 90 µM OPA and a multiple of this concentration of lysine was incubated for 10 minutes 
before it was added to the SR. In a control experiment it was shown that the added 
concentration of lysine has a negligible effect on the ryanodine binding. 
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[
3H]ryanodine binding as a function of OP A. Before the SR was pretreated with the 0.5 
µM CPM for 5 minutes at 37°C the free Ca2+ concentration was lowered to 16 nM. The 
free Ca2+ concentration was then brought back to 50 µM. The control experiment without 
CPM was done exactly in the same manner but in the absence of CPM. At 90 µM and 180 
µM OP A these two experiments were also carried out at a free Ca2+ concentration of 16 
nM. 
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The "hyperreactive" thiols labelled by CPM are apparently different from those 
labelled by OP A. This is very consistent if one remembers that CPM inhibits Ca2+ -induced 
Ca2+ release52 and OP A stimulates Ca2+ release. 
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CHAPTERV 
5 SPECTROPHOTOMETRIC ASSAY OF THE REACTIVITY 
OFOPA 
The reagent 5,5'-dithiobis(2-nitrobenzoic acid)(DTNB) was extensively used in the 
estimation of free thiol groups in native and denatured proteins. 28a This procedure is based 
on the reaction of free thiols with DTNB. The thiol reduces the disulfide of the DTNB 
molecule and forms a disulfide with one half of the DTNB. The other half of the DTNB, 
2-nitro-5-thiobenzoic acid (TNB), has a characteristic absorbance at 412 nm. There exists 
a linear relationship between free thiol concentration and the absorbance at 412 nm of this 
dianionic 2-nitro-5-thiobenzoic acid. 
From the experiments described in Figure 19, it is important to figure out if the 
OPA-lysine complex is still able to react with a free thiol. Therefore to this complex a thiol 
reagent 2-mercaptoethanol (ME) was added. To see if a reaction of ME with this complex 
occurred, this mixture was added to a solution containing DTNB and the absorbance was 
measured. 
This assay was done in the same buffer as the ryanodine binding assays. A solution 
of 1 rnM DTNB, 250 mM KCl, 15 mM NaCl, 50 µM CaCh, and 20 rnM HEPES at pH 
7 .1 was added to a cuvette of an optical pathlength of 1 cm. The spectrophotometer was 
then zeroed. The absorbance of the added solutions was then recorded at 412 nm. In order 
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to determine the free thiol concentrations, the extinction coefficient E was determined first 
by adding known concentrations of ME, varying from 10 µM to 100 µM, and recording 
the absorbance (Figure 21). As expected, a linear relationship was observed. The 
extinction coefficient£ was calculated as 12,200 M-1cm-1• 
Control measurements with 90 µM OPA, 1440 µM lysine, and a mixture of 90 µM 
OPA and 1440 µM lysine showed a negligible absorbance at 412 nm. A mixture of 90 µM 
OP A and 1440 µM lysine were allowed to react for varying amounts of time. Then an 
additional 90 µM ME was added reacting for another 10 minutes with this mixture, before 
it was added to the DTNB. The recorded absorbance is listed below in Table 5. 
Table 5 
Incubation time [min] Absorbance A Free thiol concentration [µM] 
of OPA +lysine 
10 1.058 86.7 
30 1.013 83.0 
60 1.086 89.0 
90 0.962 78.9 
These results indicate that there is a limited ability of the OP A-lysine complex to 
react with a thiol. Secondly, a longer incubation time of the OPA with the lysine doesn't 
seem to affect its reactivity with the thiol. An incubation time of 80 minutes of the OPA-
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lysine complex with 90 µM ME showed a small decrease in the free thiol concentration as 
compared with only 10 minutes incubation time. For both conditions 90 µM OP A and 
1440 µM lysine had 10 minutes time to react (Table 6). 
Table 6 
Incubation time [min] Absorbance A Free thiol concentration [µM] 
with ME 
10 1.058 86.7 
80 0.912 74.7 
The free thiol concentration of the OPA-lysine-ME complex was also measured by 
letting 90 µM OPA react first 10 minutes with 90 µM ME and then for either 10 or 40 
minutes with 1440 µM lysine. The observed absorbance is again listed below in Table 7. 
Table 7 
Incubation time [min] Absorbance A Free thiol concentration [µM] 
with lysine 
10 0.435 35.7 
40 0.278 22.8 
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One can see that a longer reaction time of the OPA-ME complex with lysine 
decreases the free ME concentration. In addition, these results indicate that ME is much 
more potent in reacting with the OPA if the lysine is added last. These observations are 
consistent with others who have shown that isoindole formation of the OP A is much 
greater if the ME is added first to OP A and then to lysine. 88 Their conclusions are based 
on fluorescence of the isoindole ring. Here, it could be shown that this statement is not 
only valid for the isoindole creation but also for the reactivity itself. 
The reactivity of OP A with ME alone was also examined. A mixture of 90 µM OPA 
and 90 µM ME were allowed 15 minutes to react before the addition of DTNB. An 
absorbance of 1.167 was measured which corresponds to a free ME concentration of 95.6 
µM. This indicates that there is no covalent bond between OPA and ME, and the ME 
reacts preferentially with the DTNB. The fact that the apparent ME concentration has 
increased following treatment with OP A is not understood, since OPA alone lowers the 
absorbance at 412 nm. 
These experiments suggest that the inability of the OPA-lysine complex to stimulate 
ryanodine binding is due to its principal inability to react with a free thiol (i.e., it can't 
react with the cysteine residues on the release protein). The fact that ryanodine binding is a 
little higher than the control (in Figure 19) can be explained in terms of the small ability of 
the OPA-lysine complex to react with free thiols. 
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Different mixtures of 90 µM OP A with 1440 µM lysine and\or 90 µM 2-mercaptoethanol was added to the 1 mM 
DTNB solution after the given reaction time. 
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4.) x = 30 min 5.) x = 60 min 6.) x = 90 min 
7.) 90 µM OPA and 1440 µM lysine (10 min incubation time); then 90 µMME (80 min incubation time) 8.) 90 µM 
OPA and 90 µMME (15 min. incubation time). 
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CHAPTER VI 
6 CONCLUSIONS 
At present it is still unknown how the T -tubule communicates with the SR to release 
Ca2+. It is unknown what the physiological reagent is which causes the Ca2+ release 
channel to open, and rapidly to close within a few milliseconds. As described in Chapter 
1.5 there are a several chemical reagents which induce Ca2+ release from the SR by 
stimulating the SR Ca2+ release channel. In order to explain the mechanism of E-C 
coupling, it is not only necessary to explain how the channel is opened, but also how it 
closes. 
In this thesis the effect of o-Phthalaldehyde on skeletal muscle SR was examined. o-
Phthalaldehyde has the characteristics that it can form a covalent bond with a sulfhydryl 
group and an amino group. The SR Ca2+ release protein is a protein composed of 
approximately 5000 amino acids. It has previously been shown that OP A is only able to 
form an isoindole complex at a protein with the amino acids cysteine and lysine. From the 
structure of the OPA molecule one can conclude that the two amino acids cysteine and 
lysine must reside or be able to move to within 3A in order to react with OP A. 
We have shown that OPA interacts with the RyR\Ca2+ release channel from skeletal 
muscle SR. Experiments with Ca2+ loaded SR vesicles showed that OPA is potent in 
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releasing Ca2+ via the SR Ca2+ release channel. GPA-induced Ca2+ release was inhibited by 
nanomolar concentrations of ruthenium red, a potent inhibitor of the Ca2+ release channel. 
[3H]ryanodine binding experiments provided a more accurate description of the 
interaction of OPA with the RyR\Ca2+ release channel. Biphasic ryanodine binding 
behavior was observed. Association experiments revealed the nature of this biphasic 
behavior. It clearly showed that OPA interacts with two different binding sites at the 
RyR\Ca2+ release channel, a low and a high affinity binding site. Binding to the high 
affinity binding site increases ryanodine binding, while binding to the low affinity binding 
site decreases ryanodine binding. Association experiments showed that even at high OP A 
concentrations, ryanodine binding is first stimulated and then inhibited as a function of 
time. OP A appears to first bind to the activating high affinity sites and then subsequently 
to lower affinity sites. 
Carrying out association and dissociation experiments, we have been able to 
calculate the dissociation constant "Ki. It was shown that OP A lowers the "Ki for ryanodine 
binding by a factor of about 1.5 at several OP A concentrations. In order to verify this 
result, and to examine the influence of OP A on the maximal number of binding sites, a 
saturation binding assay with a Scatchard analysis was performed. The concentration 
independent decrease of "Ki by OP A could be confirmed qualitatively, if not quantitatively. 
The discrepancy may be explained in the different way these two experiments were 
performed and the fact that different SR preparations were compared. For an OP A 
concentration in which ryanodine binding is stimulated maximally, Bmax is increased by a 
factor of about 2.5, while for a concentration at which OPA is already bound to the low 
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affinity binding site, Bmax decreases. With these experiments it is now understood what 
effect OPA has on the RyR. Binding to the high affinity binding site decreases the I(i (i.e., 
it increases the affinity for ryanodine binding) and increases the number of maximal 
binding sites. Since the RyR has only one high affinity ryanodine binding site, the increase 
of maximal binding sites corresponds to an opening of more RyR\Ca2+ release channels. 
Binding to the low affinity binding site doesn't influence the I(i for ryanodine binding, but 
only decreases the number of ryanodine receptors. 
This biphasic behavior of opening and closing the channel may be physiologically 
relevant. Binding or oxidation of the high affinity binding site may open the channel, and 
binding or oxidation of the low affinity binding site may close the channel. The significance 
of the low affinity binding site is not clear yet. It might be that binding of OP A to this site 
causes an irreversible damage of the RyR\Ca2+ release channel following the dissociation 
of ryanodine, or it may be that this site is really relevant for closing down the channel. The 
ryanodine binding assays can't reveal this uncertainty, since it is not an assay to reveal 
reaction kinetics. 
High affinity ryanodine binding was observed to be biphasic with increasing OP A 
concentration, Ca2+ concentration and time. Interestingly, GPA-activated ryanodine 
binding was independent of the Ca2+ concentration, indicating that there are possibly two 
classes of RyR\Ca2+ release channels present in the SR, one Ca2+ dependent and the other 
class independent. 
The inability of the reducing agent DTT to decrease OP A stimulated ryanodine 
binding clearly showed that the interaction of OPA with a sultbydryl group on the Ca2+ 
96 
release protein doesn't result in a disulfide linkage of the receptor complex, but is directly 
with the critical sulfhydryl groups. 
The [3H]ryanodine binding experiment as a function of OPA concentration with and 
without CPM pretreated SR indicates that there are at least two different sulfhydryl 
groups which are involved in channel activation. CPM is able to inhibit Ca2+-induced Ca2+ 
release and does not bind to the RyR/Ca2+ release channel if the channel is in an open 
state. This is most likely due to the fact that one of the SH groups to which CPM binds is 
disulfide linked during channel activation. The experiments performed with OP A showed 
that pretreatment of the SR with CPM doesn't effect OP A-stimulated ryanodine binding. 
This observation suggests that OP A stimulates the channel by binding to a SH group 
different than the one which CPM binds to. OPA binds to a sulthydryl group which is 
responsible for channel activation, while CPM binds to a different sulfhydryl group which 
is required for normal for channel activation under physiological conditions. Both the 
activation and inhibition of [3H]Ryanodine binding by OPA are CPM independent. 
It is still unclear if OPA reacts only with a sulfbydryl group or also with the amino 
group and forms an isoindole ring. If it reacts only with the sulfhydryl group, then the 
experiments with DTNB showed that this reaction is reversible and no covalent bond is 
formed. If it reacts with the cysteine and the lysine then this reaction is irreversible and a 
covalent bond is formed. Fluorescence experiments with the OP A treated SR should 
reveal if this isoindole is formed or not, because this complex has characteristic 
fluorescence properties. These experiments will be performed in the near future to reveal if 
the amino acid lysine is nearby the reactive cysteine. If a lysine is adjacent to the reactive 
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thiol, it is likely responsible for decreasing the pKit of the critical thiol from around pH 8 to 
pH 7. The strongest evidence for the formation of the isoindole ring was found in a bilayer 
experiment (unpublished data) in which the channel was activated by 200 µM OPA. Upon 
changing the solution to remove unbound OPA and adding back 200 µM cysteine to the 
cis chamber, channel activity as measured by the open probability remained unchanged. 
This strongly suggests that OPA is bound covalently to the RyR\Ca2+ release channel. 
When OPA binds to a cysteine on the receptor, it also binds to a lysine residue to form a 
covalent isoindole derivative. 
It has been shown that there exist critical sulfhydryl groups on the RyR/Ca2+ which 
exhibit channel gating properties similar to those observed in the native biological 
membranes. It is somewhat surprising that there are many other nonthiol reagents known 
which also open the channel. These reagents appear to induce conformational changes in 
the protein's structure such that a disulfide linked high molecular weight complex is 
formed. Yet, it is unclear why so many chemical compounds are able to interact and 
stimulate the RyR/Ca2+ release channel. One possible explanation could be that this 
behavior is a relic of evolution. The channel gating mechanism changed over time, but 
these critical binding sites are still present on the protein. If this theory is correct, the 
possibility exists that these critical sulfhydryl groups are not physiologically relevant 
anymore. Further research is needed to resolve this uncertainty. 
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